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Abstract  
Cerebral autoregulation is the homeostatic mechanism that maintains sufficient cerebral 
circulation despite changes in the perfusion pressure. Dynamic CA refers to the changes 
that occur in CBF within the first few seconds after an acute MAP change. Assessment of 
the CA impairment plays important role in the prognosis of many cerebrovascular diseases 
such as stroke, sub-arachnoid haemorrhage, as well as traumatic brain injury and 
neurodegenerative disorders. 
This thesis investigates the feasibility of using physiological MRI to estimate dynamic 
cerebral autoregulation (dCA) metrics. In particular, this thesis has an emphasis on 
measuring beat-to-beat arterial blood pressure inside the scanner to provide better 
understanding of the physiological aspects of dCA. Further, continuous blood pressure (BP) 
measures in response to different non invasive BP fluctuating methods are acquired to 
evaluate the reliability of these methods to induce response changes. 
Blood Oxygen Level Dependent (BOLD) fMRI method was used to estimate the expected 
variations of tissue oxygenation during induced dCA changes in healthy volunteers. The 
non invasive arterial blood pressure measurements were acquired using MR compatible 
arterial blood pressure monitoring device (NIBP-MRI/Caretaker; Biopac®). Further, 
sudden release of inflated thigh-cuffs (TCR) and inspiratory breath-hold (iBH) methods 
were used in the scanner to induce dynamic autoregulatory changes. These two methods 
were investigated in a pilot study, to evaluate the reliability prior to the MR study by 
comparing BP measurements obtained outside the scanner using non invasive methods. 
This pilot study included monitoring BP changes in response to four types of non invasive 
BP fluctuating methods. The reliability of NIBP/MRI Caretaker device was examined by 
comparing the BP response changes with the simultaneously acquired BP data from 
Finometer plethysmographic device. The cerebral autoregulation metrics were estimated 
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by calculating the rate of regulation (RoR) following dynamic BP fluctuating events. Rate 
of regulation defines the rate at which the BOLD signal changes depending on MAP changes 
at a particular time. Further, the tissue specific regulation parameters were obtained for 
grey matter (GM), white matter (WM) and water shed areas (WS). The effect of iBH 
method on cerebral blood flow (CBF) and velocity (CBFV) was explored in a preliminary 
study by quantitative measures using time resolved 4D PC MRI angiography in two 
subjects. 
The mean arterial blood pressure (MAP) changes in response to TCR and iBH method were 
comparable. The fMRI data demonstrated BOLD signal amplitude change in response to 
the induced fast MAP changes. The GM and WS areas showed similar rates of regulation, 
and these were nominally higher than WM RoR in both TCR and iBH methods. Further, the 
4D PC MRI data suggested 29% CBF-increase in response to 33% iBH in four minutes 
acquisition time.  
The acquired non invasive arterial BP measures concurrent with the BOLD signal amplitude 
response, allowed deriving the rate of regulation as a metric of dCA. It is not known 
whether this information is clinically relevant to gauge the haemodynamic risk association 
to cerebrovascular disease. However, BOLD signal change and CBF changes after iBH are 
confounded by the extent to which the CO2 gradually accumulate in response to iBH and 
causes an overshoot in the CBF response-change.  
In conclusion, the presented study indicates the feasibility of using physiological MRI to 
measure dCA in response to non-invasively induced MAP changes. Estimation of the dCA 
metrics could be improved by using advanced data fitting methods as well as controlling 
for physiological parameters such as PECO2.   
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Chapter one Introduction  
1.1 Background 
Autoregulation refers to the changes occurring in an organ during 
fluctuations in perfusion pressure to keep the blood flow relatively constant. 
Because of the high metabolic demands of the brain, cerebral autoregulation 
(CA) is one of the most important autoregulation mechanisms in the body 
that allows the brain to match its metabolic demands [3]. During 
physiological conditions such as low and high perfusion pressure, CA 
protects the brain from cerebral hypoxia and brain edema [1]. Cerebral 
autoregulation is impaired in many cerebrovascular diseases such as stroke 
and sub-arachnoid hemorrhage, as well as in traumatic brain injury and 
neurodegenerative disorders[2-5]. Understanding CA alterations may help 
to understand the neuronal damage related to cerebrovascular diseases, 
hence it has an important prognostic value. Establishing a simple diagnostic 
tool to estimate CA metrics is necessary in order to assess the 
haemodynamic risk association of cerebrovascular disorders [9]. Several 
physiological factors contribute to maintaining sufficient blood supply to the 
brain such as blood pressure (BP), partial pressure of end-tidal CO2 (ETCO2), 
and sympathetic tone [6]. CA metrics could be estimated by measuring the 
underling CBF and CBV changes [7]. Furthermore, the CMRO2 is another 
dynamic factor that should be accounted for when estimating CA [8].  
Measuring CA metrics should include physiological aspects associated with 
the underlying CBF changes. Recent literature has shown the necessity of 
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including all derivatives when estimating CA metrics, particularly the arterial 
BP [9]. Recent studies suggest that including BP measures improves time 
varying estimates of CA [10]. Techniques with high temporal resolution such 
as trans-cranial Doppler (TCD) allow for continuous recording of CBFV.  This 
allowed the identification of transient responses of CBFV to sudden changes 
in BP, and hence estimation of dynamic CA (dCA) [6]. This thesis focuses on 
measuring the dynamic CA metrics only, using non invasive methods.  
Estimating the dCA metrics requires high spatial and temporal resolution 
techniques. Increasing the temporal resolution of the dCA estimation 
parameters is important for two reasons; first, CA is, like other physiological 
processes, modulated by several biological factors that change over time 
[11]; and secondly, the vasoactive mechanisms that modulate 
cerebrovascular resistance, show variable degrees of non-stationarity [9]. 
Various techniques have been used to measure dynamic cerebral 
autoregulation such as Trans-cranial Doppler ultrasound (TCD), magnetic 
resonance imaging (MRI) and functional near infrared spectroscopy (fNIRS) 
[12-16]. Quantitative measures of cerebral blood flow (CBF) and velocity 
(CBFV) are dependent variables of autoregulation parameters. MRI and TCD 
measures of these parameters have been used in clinical and research 
settings to estimate CA metrics. The TCD measures of cerebral blood flow 
velocity (CBFV) have been a standard way of measuring CA metrics [12]. 
However, wider clinical application of TCD measures may be affected by the 
limited spatial resolution of the technique [17].  In the last two decades, the 
developments in the analysis and applications of functional magnetic 
resonance imaging (fMRI) have improved CA measurements with high 
temporal and spatial determinations [18-20]. 
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Furthermore, quantitative MR-imaging techniques have opened the way for 
non invasive and more reliable methods of quantifying cerebral 
haemodynamic metrics, such as dynamic susceptibility contrast measures 
of cerebral blood volume (CBV)[21], phase contrast magnetic resonance 
imaging [22] and arterial spin labelling (ASL) [23]. Determining the 
autoregulation parameters in a healthy brain is an important factor in 
establishing a physiological diagnostic tool to measure dCA metrics. In this 
chapter, the physiology of intact cerebral autoregulation will be discussed 
first, including the anatomy and histological compartments of cerebral 
circulation. Second, two types of cerebral autoregulation, dynamic and static 
autoregulation, will be described and then the impaired autoregulation and 
some pathological conditions will be discussed. Finally the MR diagnostic 
tools used to measure dCA metrics will be discussed.  
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1.2 Physiological aspects of Cerebral Autoregulation 
Cerebral blood flow remains relatively constant despite changes in the 
cerebral perfusion pressure (CPP) throughout the process of autoregulation 
[24]. Normally the CBF is estimated as about 20% of the total cardiac 
output, which measures about 700-850 ml per minute [24, 25]. When CPP 
increases, this leads to vasoconstriction, the process of narrowing the 
vascular diameter to increase the vascular resistance. Increasing the 
resistance protects the brain against the risk of hyperperfusion. 
Vasodilatation occurs in response to a drop in CPP; the vasodilatation lowers 
the vascular resistance and decreases the risk of hypo perfusion[24].  
The resistance arteries¶ smooth muscles will dilate and constrict, responding 
directly to decreases and increases in perfusion pressure, respectively [26]. 
Changes in the oxygen extraction fraction (OEF) preserve tissue 
oxygenation during changes in CPP [27]. Thus the cerebral blood flow is 
preserved through a complex mechanism of metabolic and vascular motor 
function.  
Cerebral autoregulation provides sufficient blood supply to match the 
metabolic rate of brain. When the metabolic rate elevates in response to 
neural activation, the CBF increases to reach the metabolic demands, and 
thus the concept of cerebrovascular reactivity (CVR) arises [28, 29].  
Neurovascular coupling is a term used to describe the process of coupled 
neural activity and cerebral metabolism activity that is facilitated by 
vasoactive mechanisms. Multiple mechanisms participate in maintaining a 
constant CBF such as myogenic, metabolic and local neurogenic factors [9]. 
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Cerebrovascular reactivity provides the basics for neurovascular coupling, 
which may interfere with the autoregulation of cerebral blood flow. Cerebral 
autoregulation is abolished if vessels fail to dilate and constrict in response 
to neural activations [30]. 
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1.2.1 Static and dynamic cerebral autoregulation  
Cerebral autoregulation comprises cerebral arteriolar vasodilatation and 
vasoconstriction in response to fluctuations in the mean arterial blood 
pressure. This could EHGHVFULEHGDV³VWDWLF´FHUHEUDODXWRUHJXODWLRQ, which 
is the ability of CBF to respond to longer lasting changes in MAP, and 
³G\QDPLF´&$, which refers to the changes that occur in CBF within the first 
few seconds after an acute MAP change [31].  Thus there are two types of 
CA evaluation, the static and the dynamic approach. The steady-state 
(static) evaluation of cerebral autoregulation is the basis for the classical 
autoregulation curve (Figure 1). The static autoregulation metrics are 
estimated by measuring CBF at a constant baseline arterial pressure, 
followed by another CBF measurement that is taken after the ABP 
manipulation and the corresponding autoregulation response have been 
completed [32]. Lassen et al (1959) were the first to describe the static CA 
in humans, by measuring CBF using the Kety-Schmidt technique [33]. This 
method of CA evaluation usually requires invasive and long-term 
pharmacological interventions to alter arterial blood pressure [34]. During 
static CA testing, autoregulation is said to be impaired, if the CBF changes 
significantly with either an increase or decrease in MABP [35]. In the case of 
intact CA, the blood flow is maintained at or near the baseline level.  
The vasomotor control of cerebral circulation is mediated by metabolic, 
myogenic and neurogenic mechanisms including the excretion of chemical 
mediators and metabolites that require a finite time-interval to effect 
changes in vascular response [6]. Therefore, it is predictable that the CBF 
response to sudden ABP changes also takes a finite amount of time to 
complete [36]. The development of high temporal resolution techniques that 
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allow continuous recording of CBF changes has opened the door for 
developing a dynamic approach to CA estimation. Dynamic CA testing 
includes measuring CBF changes in response to rapid concomitant ABP 
changes. Evaluating the dynamic CA response provides information about 
the latency as well as the efficiency of autoregulatory action, which may be 
relevant to some clinical conditions such as traumatic brain injury [34]. A 
variety of pathological conditions including brain trauma, sub arachnoid 
haemorrhage and ischaemic attack affect the autoregulatory abilities to 
variable extent[6].  
Classic cerebral autoregulation studies are performed in a semi-steady state 
in which the CBF values reflect the results of a cerebrovascular response that 
is adapted to a gradually increased level of BP [24]. In other words, the static 
CA study assesses the outcome of autoregulation performance rather than 
the process. Autoregulatory capacity may be partially or totally lost after a 
stroke or sub-arachnoid haemorrhage [6]. Therefore, it might be important 
to evaluate and even monitor the effectiveness of cerebral autoregulation in 
such patients. Dynamic cerebral autoregulation assessment could be non 
invasive and less prolonged, pharmacological BP interventions are not 
required and it could be performed at the bedside using trans cranial Doppler 
ultrasound [24, 34].  
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Figure 1 Classic cerebral autoregulation curve [32] 
A: Schematic representation showing the characteristic autoregulation 
curve of cerebral blood flow against changes in perfusion pressure adopted 
by Panerai et al 1998 from the original CA curve by Aaslid R et al. Points L1 
and L2 represent the limits of autoregulation. The effects of hypercapnia and 
sympathetic nerve activation are also shown as examples of interventions 
that can shift CA curve. B: Pressure flow resistance graph, assuming CBF1 
at CPP1, the dynamic linear curve R1 would drop an equal percentage 
amount of CBF2 if pressure drops to CPP2. After some delay autoregulation 
becomes effective and changes the resistance to R2, whereby flow is 
restored to very near its original value [37].  
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1.3 Cerebral circulation  
Structural and functional properties of the cerebral circulation allow the 
brain to match the high metabolic demand and the need for tight water and 
ion homeostasis. Tight water regulation is necessary in the brain because it 
has limited capacity for expansion within the skull. The unique cerebral 
endothelium, known as the blood brain barrier (BBB), has specialized tight 
junctions that do not allow the free transfer of electrolytes and metabolites. 
Large extracranial and intracranial arteries contribute significantly to 
vascular resistance in the brain, unlike in the peripheral organs, where the 
majority of vascular resistance resides in small arteries and arterioles.  The 
following two sections briefly discuss the distribution of cerebral vasculature 
and physiological aspects of the blood brain barrier.   
1.3.1 Circle of Willis 
Blood is supplied to the brain mainly through a complex network of arteries 
called the Circle of Willis (CoW). This is divided into three types of arteries: 
afferent, efferent and communicating arteries.  [38, 39]. The afferent 
arteries, namely the internal carotid (ICA) and vertebral arteries (VA), are 
those arteries that supply blood to the circle. The efferent arteries take blood 
from the circle to the brain and they can be divided into the anterior, middle 
and posterior cerebral arteries (ACA, MCA, and PCA). They are connected to 
each other by anastomosing arteries, which consist of the anterior and 
posterior communicating arteries (ACoA, PCoA) [40] (Figure 2). The 
composition of the Circle of Willis varies from person to person; only half of 
the population have a complete circle [41]. 
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Cerebral venous drainage is through superficial sinuses and deep veins. The 
superficial system is mainly composed of dural venous sinuses. Walls of 
sinuses consist of dura mater, which is a thin and valveless wall. Superior 
sagittal sinus flows over the sagittal plane inferiorly and superiorly to join 
with the deep drainage system, which comes from the straight sinus, in the 
confluence of sinuses. Eventually the venous blood will drain into the jugular 
vein to be finally drained into systemic circulation via the superior vena cava 
[42, 43].  
As the arterial system of the brain is not anastomosed directly with the 
venous system, the leptomeningeal network covers the entire brain with a 
network of non-anastomosed arteries and veins in between the surface of 
the brain and the arachnoid membrane. The arterial network consists of 
arteries, arterioles and arterio-arterial anastomoses. There are small muscle 
sphincters located in the junction between cortical arteries and the 
parenchyma, which are known to control the blood flow. The blood flow is 
controlled directly by vaso-motility (dilatation or constriction) of pre-
capillary sphincters [25].  
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Figure 2 Circle of Willis (CoW), Time of Flight Angiography (ToF) 
Time of flight (ToF) sequence (23 years male subject), multiple 2D slices 
are reconstructed by maximum intensity projection (MIP) technique to show 
3D image of circle of Willis prior to 4D phase contrast MR angiography 
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1.3.2 Blood Brain Barrier BBB 
In contrast to the systemic circulation, cerebral vasculature does not allow 
the free transfer of metabolites and electrolytes through capillary beds. A 
combination of physical and metabolic barriers protecting the brain, it 
consists of tight junctions and enzymatic barriers called the blood brain 
barrier (BBB). The BBB allows necessary nutrients to pass through the 
barrier whilst it restricts the permeability of non-necessary metabolites and 
toxic substances. This selective permeability is controlled by the central 
nervous system¶V (CNS) need for nutrients. The CNS capillary beds act as a 
blood- extra cellular (ECF) barrier. The tight junctions surrounding the 
endothelial cells, similar to the choroid plexus endothelium, characterize it. 
Pericytes available in capillary walls act as receptors for the vasoactive 
mediators such as angiotensin II, vasopressin, norepinephrine 
(noradrenalin) and phagocytosis. These cells adapt to pathological 
conditions by undergoing morphological and histological changes. They 
adapt to chronic hypertension by hypertrophy, hyperplasia and the 
production of cytoplasmic contractile protein filaments. The BBB breaks 
down in many diseases such as hypertension, tumour, trauma and infection 
[44]. 
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1.4 Impairment in cerebral auto regulation 
1.4.1 Cerebrovascular reserve and misery perfusion 
Misery perfusion is a condition of cerebral circulation in which regional blood 
flow is reduced relative to the regional metabolic demand for oxygen, which 
might be caused by arterial stenosis or occlusion.  It is defined by increased 
oxygen extraction fraction (OEF) [30]. Such a state of inadequate cerebral 
metabolism may result in some critical pathology including irreversible 
changes in cerebral white or grey matter. Misery perfusion was described 
for the first time in 1981 by Baron [45]. Misery perfusion occurs during 
several chronic cerebrovascular pathologies. The literature data show the 
association between increased risk of stroke and misery perfusion. In 
symptomatic major cerebral artery disease misery perfusion is a predictor 
of subsequent stroke [46]. Thus, the identification and management of 
patients with misery perfusion is essential to further improve their 
prognosis. Aoi et al (2012) used the phase relationship between MABP and 
CBFV to assess dCA in elderly patients with chronic ischaemic infarction. 
Their results showed that better dynamic cerebral perfusion regulation is 
associated with less atrophy and better long term functional status [47].  
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1.4.2 Cerebral Autoregulation and Hypertension 
Hypertension is defined as a blood pressure level of more than 140/90 
mmHg over several repeated measures. This is according to the Seventh 
Report of the Joint National Committee on Detection, Prevention, Evaluation 
and Treatment of High Blood Pressure (JNC 7) [48]. Malignant hypertension, 
ZKLFK LV GHILQHG DV D %3 RI  , has direct effects on cerebral 
autoregulation [49]. Chronic hypertension may shift the upper and lower 
limits of cerebral autoregulation.  Immink et al (2004) observed a 
simultaneous decrease in the middle cerebral artery blood velocity (MCA V) 
with a reduction in the arterial blood pressure induced by an intravenous 
antihypertensive drug (sodium Nitroprusside SNP). They suggested that the 
static as well as the dynamic CA are affected by high arterial blood pressure 
levels [50]. Recent study findings suggest that the duration and rate of 
fluctuation of BP should be targeted in the prevention and treatment of 
cerebrovascular complications [51]. A chronic state of high blood pressure 
is a predisposing factor for a number of cerebrovascular diseases including 
hemorrhage, atherosclerosis, BBB dysfunction, carotid stenosis and 
lipohyalinosis [51]. It is established that acute and chronic hypertension are 
predisposing factors for severe cerebrovascular diseases. There are multiple 
underlying parameters that detect the severity of hypertension effects on 
cerebrovascular circulation. Hypertension alters the structure of cerebral 
blood vessels by producing vascular hypertrophy and remodeling [44]. 
Furthermore, it promotes atherosclerosis in larger arteries and lipohyalinosis 
in penetrating arteries [52]. These structural changes can compromise 
cerebral perfusion or alter cerebral autoregulation [53]. Ischaemic damage 
to the cerebral tissue probably occurs during spontaneous dips in arterial 
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pressure in the presence of arterial narrowing by lypohyaline deposits and 
atheromatous lesions. Sudden pressure elevations may also provoke 
ischaemic damage to the brain tissue in long lasting arterial spasm [53]. 
Local factors such as disturbed cerebral perfusion probably determine the 
site of infarct or the risk of haemorrhagic change.   
Several studies depended on pharmacological modifications of ABP to 
measure steady state CA metrics in patients with cerebrovascular diseases 
[54, 55]. However, developing non invasive physiological diagnostic tools 
that are applicable for hypertensive patients is necessary in order to avoid 
pharmacological induced complications in this group of patients.
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1.4.3 White matter hyper intense lesions (Leukoaraiosis) 
White matter hyperintense lesion (WMHL) is a clinical condition that consists 
of subcortical small ischaemic lesions, also known as leukoaraiosis [56]. 
These hyperintensities are observed on T2 weighted and fluid attenuated 
inverse recovery sequence (FLAIR) MR images. They are usually considered 
as an incidental finding in normal aging but are also associated with 
neurological and cognitive disorders [57]. Recent literature indicates the 
presence of hyperintense lesions in subcortical grey matter regions and 
brain stem [57]. The collective term should be subcortical hyperintensities 
if the grey matter and brain stem lesions are included.  White matter 
hyperintensities are indicative and a consequence of small vessel disease, 
and are thus associated with a high risk of stroke, dementia and mortality 
[58]. The presence RI:0+/LQ$O]KHLPHU¶VGLVHDVHKDVEHHQDVVRFLDWHGZith 
reduced cognitive function [58]. The pathophysiology of WMHL is not well 
established yet.  It LVWKRXJKWWKDWLQ$O]KHLPHU¶VGLVHDVHKLJKHU:0+/ is 
associated with higher amyloid beta deposits, which is possibly related with 
small vessel disease and amyloid clearance [59]. 
Support for the hypothetical ischaemic origin of Leukoaraiosis could be 
derived from studies based on estimating CBF changes. Fazekas et al 
(1988), in a group of WMHL patients, noted higher blood flow frequency in 
extracranial carotid arteries, and lower mean blood flow velocity in grey 
matter [60]. Impaired autoregulation is identified as a significant and 
independent determinant of the severity of leukoaraiosis lesions [61] . 
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Several studies have reported whole brain or GM alterations in the CBF of 
patients with WMHL [62-64].  
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1.4.4 Stroke risk association with auto regulation 
Stroke is an acute neurological deficit caused by vascular pathology. There 
are two types of stroke: ischaemic stroke due to lack of blood flow, and 
haemorrhagic stroke due to bleeding. Ischaemic stroke is usually caused by 
athero-thrombotic emboli. Hypertension has been identified as a major 
predisposing factor for stroke and primary cerebral hemorrhage [45]. Zia et 
al (2007) observed an increased risk of both ischaemic and hemorrhagic 
stroke in hypertensive patients [65].  
After stroke, the autoregulatory capacity may be partially or completely 
impaired rendering CBF dependent on BP. Therefore, it could be argued that 
in post-stroke patients, BP should be well controlled in order to stabilize CBF 
and prevent cerebral hypo perfusion and ischaemia Nevertheless, the 
acceptable BP levels after stroke are still not known [66, 67].  
After stroke there is insufficient blood oxygenation to the whole or a part of 
the brain as a result of disturbed circulation. In such situations, the brain 
will extract more oxygen from the blood to preserve a relatively constant 
cerebral metabolic rate of oxygen (CMRO2). Oxygen extraction fraction 
(OEF) is the ability of the brain to detach oxygen from oxyhaemoglobin to 
satisfy the high metabolic demands. Measuring the increase in OEF is 
important in the prognosis of stroke [65]. Yamauchi et al (1999) used PET 
to estimate OEF in stroke patients. The absolute value of OEF was examined 
in addition to the asymmetry of OEF. They recognized ³LQFUHDVHG-OEF´ as a 
strong predictor of 5-y recurrent stroke. Their data suggests that the 
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absolute values of increased OEF are independent predictors of future stroke 
[5].  
Calibrated BOLD MRI is a non invasive technique that can measure the OEF 
of cerebral tissue [68]. There are several applications of fMRI in the 
diagnosis and follow-up of stroke patients. In addition to the estimation of 
diagnostic parameters such as OEF, functional MRI can be used to diagnose 
the likely source of stroke by measuring the territorial cerebrovascular 
metrics [69]. 
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1.5 Measuring dynamic cerebral autoregulation 
The dynamic CA is estimated by measuring the continuous CBF before and 
after an induced arterial BP disturbance [9]. There are a number of 
observable parameters that are used in CA metrics, such as cerebral blood 
flow (CBF), blood volume (CBV), and cerebral blood flow velocity (CBFV). As 
described previously, dCA metrics are usually measured in response to a 
haemodynamic-perturbing stimulus. The haemodynamic response function 
to a stimulus occurs within a fraction of a second [70]. Therefore, measuring 
dCA changes requires high temporal resolution techniques. Furthermore, 
recent literature shows regional variation in dCA metrics. Horsfield et al 
(2013) estimated dCA metrics using a 1.5T MR scanner for ten healthy 
volunteers. Thigh-cuff release was used to induce dynamic BP changes and 
autoregulatory index was used to estimate CA changes. They observed 
different dCA efficiencies in GM, WM and cerebellum [22].  It is necessary 
to establish diagnostic tools that provide sufficient spatial and temporal 
resolution to estimate dCA metrics.  
Usually, the dynamic cerebral autoregulation (dCA) metrics are estimated 
using parameters extracted from the time or frequency domain. The 
physiological determinants of dCA metrics are strong indicators of the non-
stationary nature of dCA [9, 71]. Therefore, developing techniques that 
allow multiple physiological interpretations of measured parameters are 
necessary to allow the application of dCA measurement in health and 
pathological states. 
Several diagnostic tools are used to quantify cerebrovascular reactivity 
metrics such as, positron emission tomography (PET), functional near-
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infrared spectroscopy (fNIRS), trans-cranial Doppler (TCD) and functional 
magnetic resonance imaging (fMRI). The availability and feasibility of some 
of these techniques has hindered their application. TCD and MRI are the 
most frequently used techniques in clinical and research settings.  
The MRI technique is a characteristically fast and non invasive method that 
allows visualisation of tissue boundaries as well as functional quantification 
of neuronal activities. Today, functional neuroimaging allows for the 
quantification of parameters such as CBF and CBV within milliseconds. With 
advanced imaging techniques such as endogenous contrast arterial spin 
labelling (ASL) MRI, it is possible to quantify the flow of blood through 
cerebral vessels [72]. Blood oxygen level dependent (BOLD) MRI can 
indirectly measure modulations induced pharmacologically or physiologically 
in the blood flow or volume through calibrated methods [8, 73]. Phase 
contrast (PC) MRI is another contrast-free angiographic technique that 
allows vessel specific quantifications of CBV and CBF. Time resolved three 
dimensional (4D flow) MRI allows 3D visualization of neurovascular anatomy 
and flow direction with full volumetric coverage in an easy 3D acquisition 
[74]. Observing cerebral blood flow and volume changes requires fast 
techniques, in order that the image acquisition has the same frequency as 
the fast cerebral haemodynamic changes. 
Measuring dCA not only requires a fast physiological acquisition tool but also 
a repeatable BP-fluctuation method. Cerebrovascular reactivity responses 
can be induced pharmacologically or non-pharmacologically. 
Pharmacological interventions are indicated in studies that measure steady 
state changes of CA [75]. Several non invasive interventions have been used 
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to induce fast changes in the systemic blood and estimate corresponding 
CBF changes, as described in the first chapter of this thesis.  
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1.6 Functional magnetic resonance imaging 
The concept of a close temporal relation between the haemodynamic 
response and cerebral neural activation is not new. For more than a century, 
scientists have observed the relationship between the haemodynamic 
response and neural activation [76]. Ogawa et al were the first to observe 
an MRI signal decrease from deoxygenated blood in a T2* weighted image, 
at the beginning of the nineties of the last century [77]. The functional MRI 
(fMRI) signal change depends on the level of paramagnetic 
deoxyhaemoglobin in the blood. The paramagnetic nature of 
deoxyhaemoglobin produces different magnetic susceptibility in between the 
blood vessel and the surrounding tissue [8]. Because of the different 
magnetic properties of oxyhaemoglobin and deoxyhaemoglobin, they give 
different signals on MRI. The former is diamagnetic and gives an opposite 
magnetic field, but the latter has a non-zero magnetic moment that gives 
weak attraction to a magnetic field.  
The haemodynamic response occurs after short neural activation that 
produces a specific BOLD signal. Haemodynamic response function has been 
examined by several research studies. Generally, it is distributed over three 
preliminary key features: first the initial dip, then the positive overshoot and 
finally the post-stimulus undershoot [78].  
There are different views about the detection of the initial dip at different 
field strengths, as it has been observed that even at high field strength it 
cannot always be detected [79]. 5-6 seconds after a neurovascular event 
the oxygenation level will reach its maximum level, at which the BOLD signal 
effect will be acquired. Following this, the BOLD signal dips down to more 
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than its original baseline; this is called the ³SRVW-VWLPXOXVXQGHUVKRRW´7KH
mechanism behind the post-stimulus undershoot is controversial. It might 
be explained by the large amount of deoxyhaemoglobin that persists in the 
blood because of the delay in CBV recovery that follows the CBF changes 
[80].  However, it could also be explained in the light of the hypothesis that 
supports coupled CBF and CBV, but considers the CMRO2 as a distinct 
parameter [81, 82]. 
The increase in blood flow following neural stimulus and the associated 
increase in cerebral metabolic rate of oxygen CMRO2 are the basics for 
observed BOLD signal amplitude response [83]. However, the baseline 
physiological state is also a strong determinant of the BOLD signal amplitude 
response. The baseline physiological state is determined as the total 
deoxyhaemoglobin present in a voxel, which is a function of several 
parameters such as hematocrit, OEF and CBV [84]. As long as these baseline 
parameters are unknown, the BOLD signal cannot be considered as a 
quantitative measure of cerebral haemodynamic response [83]. 
Researchers have sought to measure baseline physiological variables using 
the calibrated BOLD method [85]. The key component of the calibrated 
BOLD method is accurate modelling of the BOLD signal amplitude depending 
on the underlying physiological changes [86]. Although the BOLD signal is a 
qualitative method, the calibrated BOLD experiment offers the potential to 
use the BOLD signal as a quantitative probe of brain physiology.  
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1.6.1 Calibrated BOLD and hypercapnia method 
The theory behind calibrated BOLD is an exact mathematical expression of 
BOLD signal amplitude in relation to the underlying physiological changes 
[83]. Fully oxygenated blood has approximately a 40% oxygen exchange 
rate at the capillary bed transit time [87]. This results in a certain amount 
of deoxyhaemoglobin in venous capillary vessels. [88].  A classical positive 
BOLD signal occurs when there is a decrease in the level of 
deoxyhaemoglobin, which leads to a signal increase [89]. The CBV 
contributes to this by changing the total amount of deoxyhaemoglobin 
available in a voxel [90].  
Previously Davis et al (1998) represented the BOLD signal as [91]: 
ߜܵ ൌ ܯሾ ? െ ݂§ ൬݂ݎ൰ሿé 
In which, į6  %2/' VLJQDO FKDQJH SHUFHQWDJH f=CBF, r=CMRO2 ratio 
(activation/baseline), and æ and ǃare the model parameters 
The local deoxyhaemoglobin level directly affects the BOLD signal amplitude, 
at a constant rate of CMRO2. Thus the signal amplitude is affected by the 
physiological parameters that affect the local deoxyhaemoglobin level [85]. 
The above equation is a specific approach; Blockley et al (2011) have used 
a more general approach: 
߂ܵ ൌ ܤ݄ሺ݂ǡ ݎሻ 
Ʃ6 %2/'VLJQDOFKDQJHSHUFHQWDJH 
B=calibration parameter 
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H (f, r) =function, describes changes in CBF and CMRO2 of the BOLD 
changes. 
 
In this model, which includes different blood compartments such as arterial, 
capillary, venous and extravascular compartments, they assumed that the 
new calibration method is unrestrained by the respiratory challenge, in the 
case that hypercapnia calibration is considered as a consistent method [83].  
Switching between hypercapnic and normocapnic intervals leads to changes 
in the CBF and hence can achieve changes in the deoxyhaemoglobin level in 
the brain. Since the BOLD signal depends on the level of 
oxy/deoxyhaemoglobin in the blood, physiological events that alter the 
blood oxygenation level can non-invasively be detected as BOLD amplitude 
change in gradient echo proton images [83].  
Hypercapnia causes a gradual accumulation of CO2, which is a potent 
vasodilator. Vasodilatation can be pharmacologically induced by drugs such 
as acetazolamide or it can be induced by increasing the amount of CO2 
inhaled using breath holding methods [92].  
In this thesis respiratory challenge was used to induce transient hypercapnic 
response changes in the brain. It has already been validated that short 
periods of breath holding as well as changes in the rate and depth of 
respiration induce a sufficient hypercapnic response, and the effects of the 
hypercapnia on cerebral circulation could be estimated by measuring the 
corresponding BOLD signal change to respiratory challenges [93, 94].  
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1.6.2 Phase contrast magnetic resonance angiography (PC MRI) 
Flow-sensitized 3D phase contrast magnetic resonance imaging (4D PC 
MRI), also known as time resolved 3D magnetic resonance angiography 
(MRA) has been introduced recently. Magnetic resonance angiography can 
assess haemodynamic changes in normal or diseased cerebral vasculature 
[5-7]. The role of PC MRI in the diagnosis and characterization of 
cardiovascular diseases has been established [95, 96]. The flow measures 
obtained with 4D PC MRI correlate well with the measures obtained with 
reference modalities such as TCD, TCCD at specific cerebral vessels [74].  
To date, TCD has been the standard modality for measuring flow velocity in 
the cerebral blood vessels. However, the lack of angle correction for 
measured velocities and the limited spatial coverage are drawbacks of this 
method. 4D PC MRI allows multidirectional velocity sensitization, vessel 
diameter measurement, as well as very high temporal information coupled 
with the cardiac cycle. In the following paragraph, the physics behind phase 
contrast imaging is discussed briefly.  
The transverse component of spin magnetization acquires a motion induced 
phase shift. Thus, transverse magnetization should be induced first by the 
radiofrequency pulse before adding the flow sensitizing gradients [97]. Two 
main types of images are acquired in phase contrast imaging: a magnitude 
(modulus) and a phase (velocity) image. The magnitude image resembles a 
classic bright-blood image and contains anatomical information. In the 
phase image the grey value represents the velocity information in that voxel, 
where the black indicates flow direction towards the viewer and the white 
represents flow away from the viewer [95].  Velocity encoding detects the 
highest and lowest velocity encoded by the sequence and it is given in units 
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of centimetre/second (i.e. velocity encoding=100cm/s describes a phase 
sensitizing experiment with a measurable range of velocities ±100 cm/s) 
[97]. 
2D phase contrast MRI with partial spatial coverage and unidirectional 
velocity encoding provides haemodynamic information about cerebral 
vessels.  A combination of 2D phase contrast and a breath-hold test has 
previously been used to estimate the dynamics of CA [98]. The results 
support capability of 2D PC MRI to measure the cerebrovascular responses 
to transient hyperaemic responses for short breath-holds of 30 seconds. 
  
 
 
43 
1.7 Non invasive methods to induce blood pressure fluctuations 
1.7.1 Sudden release of inflated thigh-cuff 
Thigh-cuff release was first introduced by Aaslid et al (1982) to induce 
sudden drops in the systemic BP [6]. To study dCA, a step response change 
should be induced in the CPP to allow for observing the CBF changes before 
and after that. Concurrent measures of CBF and ABP from TCD and 
Finometer respectively have been used as a standard method to derive dCA 
metrics [17, 22, 99]. 
Maintaining inflated bilateral thigh-cuffs (20 mmHg above the systolic BP of 
the subject) for two or three minutes is used to induce a step change in ABP 
[6, 22].    The sudden release of the thigh cuffs induces a rapid BP drop in 
less than a second [100]. This step response prompts corresponding 
changes in the CBF that can be used to plot an autoregulatory response 
index over several measures [34]. Measuring the CBF rate of regulation  
(RoR) in response to step-wise changes in BP is a completely non invasive 
and non-pharmacological method that can provide physiological information 
on autoregulatory gain and cerebral vasomotor state [6].  
The sudden release of thigh-cuffs could have important clinical application 
for evaluating the effect of anaesthetic agents in clinical care unit patients 
[31, 101]. Furthermore, it has been applied in patient groups such as those 
with orthostatic hypotension [102], trauma [103], and carotid artery 
stenosis [104].   
To evaluate the repeatability and robustness of the method, it is necessary 
to systematically evaluate it by comparing the results in between different 
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groups of subjects and also with other non invasive modalities that have 
been used to induce a step-wise BP decrease. This will be discussed 
systematically in chapter 2.  
1.7.2 Respiratory challenges 
Respiratory challenges have been used by many researchers to activate 
dynamic cerebral autoregulation [18, 93, 94, 105].  Different respiratory 
challenges introduced to induce hypercapnic response include breath-hold 
and cued deep breathing.  The physiological aspects associated with both 
methods include hypertension, bradycardia, CO2 retention and oxygen 
conservation [106]. Respiratory challenges have been used in patients and 
healthy subjects of different age groups to estimate dCA measures [93, 94, 
98, 107]. 
Breath holding starts with the voluntary inhibition of respiratory muscular 
activity, and is maintained by controlled closure of the glottis [108]. 
Changes in the rate or depth of respiration, known as cued deep breathing 
(CDB), can also induce a hypercapnic response [109]. CDB consists of a 
rhythm of self-paced breathing interleaved with a set of repeated deep 
inhalations and exhalations [93]. Recent studies have shown that even 
subtle variations in the rhythm of respiration can induce a BOLD signal 
change [110].  
Despite the motor activations associated with breath-hold performance, 
there are many other mechanisms associated with breath holding.  
Hypercapnia and the vasodilatory effects of CO2 on cerebral vessels is the 
main mechanism described. The chest movement associated with the 
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respiratory challenge itself can induce magnetic field changes and lead to 
image distortions [111].  
Another physiological alteration associated with breath holding is systemic 
arterial blood pressure changes. This can be derived from the sympathetic 
activation as well as the volumetric changes in the circulation associated 
with the changes in thoracic cavity pressure [112]. These changes do not 
occur immediately and they prompt fluctuations in the rate of cerebral blood 
flow and oxygenation, during which the dCA mechanism is activated to 
compensate for the transient changes and maintain constant blood flow in 
the brain. 
Less attention has been paid to the ventilatory effort occurring at the 
beginning of a breath hold. An inspiratory breath-hold (iBH) is different from 
a non-inspiratory breath-hold (BH). Transient sub-atmospheric pressure 
generated at the beginning of an iBH may affect the physiological 
parameters associated with the breath-hold performance [108]. Since the 
dCA measurements depend on the fluctuation rates of cardiovascular 
parameters, especially BP, it is important to standardize the respiratory 
interventions that induce concomitant BP changes.  
The repeatability of respiratory challenges for different groups and settings 
as well as the role of the method in estimating dCA metrics is evaluated 
systematically in the following chapter.  
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1.8 Conclusion 
As described previously, measuring CA metrics is indicated in the prognosis 
of several cerebrovascular diseases. However, the standard diagnostic tool 
should be optimized first to examine CA in healthy brain. The physiological 
parameters of CA metrics are complicated even in a standard context. With 
the wide range of diagnostic tools and interventions available, it is 
fundamental to develop a single diagnostic tool that can be applied in 
healthy and patient populations. 
Developing a physiological diagnostic tool to measure CA metrics requires 
answering a few fundamental questions. For example, what is the most 
consistent method used to quantify CA metrics? And what is the most robust 
method to induce BP fluctuation? 
The following chapter includes a systematic review of the literature to 
evaluate the main techniques and interventions that have been used to 
measure CA metrics in the last ten years. 
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 Chapter 2  
2 Systematic Review of Literature 
2.1 Introduction 
 
In the previous chapter the significance of CA metrics in the prognosis and 
follow-up of various cerebrovascular diseases was discussed. ³Pressure 
DXWRUHJXODWLRQ´ LV WKH FRPPRQ approach used to test cerebral 
autoregulation in relation to changes in the mean arterial blood pressure. 
Different diagnostic methods have been used to assess dCA metrics. This 
review systematically inspects non invasive studies that have examined 
cerebral autoregulation in the last ten years (2003-2013), addressing the 
following questions: 
1) What is the best non invasive physiological method to measure CA?  
2) How consistent are the methods that have been applied as diagnostic 
tools to measure CA? 
Evaluating the consistency and repeatability of dCA diagnostic methods 
requires the precise synthesis of some other physiological aspects, such as:  
x The main anatomical regions of interest evaluated so far in the literature, 
and the limitations of wider coverage of specific diagnostic tools.  
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x The interventions used to stimulate blood pressure (BP), and their influence 
on the CA measurement efficiency. 
x The autoregulation indices that have been used to quantify dynamic 
response changes.  
x The general and specific limitations in measuring CA 
x The future direction with regard to developing a simple consistent 
physiological diagnostic tool to assess CA.  
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2.2 Methods 
The study was FRQGXFWHG DFFRUGLQJ WR ³SUHIHUUHG UHSRUWLQJ ,WHPV IRU
Systematic Reviews and Meta-$QDO\VHV7KH35,60$6WDWHPHQW´[15]. The 
literature search was executed by searching the database of the National 
Center of Biotechnology Information (PubMed-NCBI) and the National 
/LEUDU\ RI 0HGLFLQH¶V 0HGOLQH (Ovid) database, using the following key 
words:  
x ³Cerebral DXWRUHJXODWLRQ´and 
x ³Arterial EORRGSUHVVXUHIOXFWXDWLRQV´ 
x 25³DUWHULDOEORRGSUHVVXUH´ 
x 25³FHUHEURYDVFXODUUHVHUYH´ 25³&95´ 
x 25³FHUHEUDOEORRGIORZ´25³&%)´ 
x 25³FHUHEUDOEORRGYROXPH´25³&%9´ 
x 25³%2/'05,´25³EORRG-oxygen level dependent magnetic 
resonance imaging´ 
x 25³$6/05,´25³DUWHULDOVSLQODEHlling magnetic resonance 
LPDJLQJ´ 
x 25³7&'´25³WUDQV-FUDQLDO'RSSOHU³ 
x 25³+5)´25³KHPRG\QDPLFUHVSRQVHIXQFWLRQ´ 
x 25³QHXURYDVFXODUFRXSOLQJ´ 
x 25³FHUHEUDOPHWDEROLVP´ 
x OR ³,+*7´25³KDQGJULSWHVW´ 
x 25³EUHDWKKROGWHVW´ 
x 25³+\SHUFDSQLD´25³K\SRFDSQLD´25³K\SR[LD´25³K\SHUR[LD´ 
x 25³KDQG*ULS´25³KDQGJULSWHVW´25³LVRPHWULFKDQGJULSWHVW´
25³,+*7´25³+*´25³+*7´ 
The search was restricted to papers published between 2003 and 2013 
because of the time limitation of the study. Furthermore, the search criterion 
was restricted to the last ten years in order to include the latest technical 
advances and analysis methods. All of the papers included were published 
in English and they included only in-vivo adult human brains. It is known 
that the pathophysiological mechanism of flow autoregulation is different in 
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neonates [113]. Therefore neonate studies were excluded from this 
synthesis.  
Studies that estimated the mechanisms of flow regulation in animals were 
excluded from this review because the main aim is to evaluate simple non 
invasive techniques that have been used to assess dCA metrics in human, 
which are clinically valid and accessible.   
 Estimating the dynamics of CA is usually performed through CA indices that 
calculate the function of CBFV response according to the ABP changes. This 
kind of investigation requires continuous CBFV measures. Trans-cranial 
Doppler and functional MRI are both non invasive techniques that can 
provide continuous haemodynamic metrics over several minutes. This 
review includes only CA studies that used TCR and fMRI to quantify the 
haemodynamic metrics.  Studies that used techniques such as PET or fNIRS 
were excluded from this review to facilitate the comparison of autoregulation 
indices. Furthermore, TCD and fMRI techniques are less invasive and more 
commonly used in clinical settings.  
After being reviewed for their population characteristics and diagnostic 
methods, the eligible studies were assembled in a spreadsheet format for 
analysis. The features recorded included population demographics, methods 
of measurement, type of intervention, recorded physiological measures, 
imaging and/or ultrasound characteristics, statistics performed, and 
methods of analysis (autoregulation indices). The percentage or numerical 
records of arterial blood pressure change could not be obtained from the 
majority of the studies, which was a reason for excluding them.  
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2.3 Results 
The first database search resulted in a large number of studies (more than 
900,000). The search was then restricted to include studies from 2003-
2013; this resulted in about 400,000 studies. The following parameters 
(infants, animal studies, non-clinical, and non-English published studies) 
were used to filter the search down to 375 studies (Figure 3). These were 
scanned for the titles and 202 studies were excluded for being totally 
irrelevant, within which there were 16 animal studies and one neonate study 
that had not been identified during the first line filtering.  From the 
remaining 173 studies, a further 102 papers were excluded, as 45 studies 
included invasive methods and intraoperative patients, and 57 studies 
included other acquisition methods such as PET, angiography and fNIRS.   
In total, 71 papers were reviewed, of which 37 studies (including review 
papers) were excluded because the methodology was irrelevant to the 
current study. 
Finally, 34 studies were selected to be involved in the synthesis (Figure 3).  
19 of them used functional magnetic resonance imaging fMRI and the rest 
used Trans-cranial Doppler (TCD). Within the MRI studies, three studies 
included patients with Moyamoya disease, internal carotid artery ICA 
stenosis and subarachnoid hemorrhage (SAH). The rest of the studies used 
TCD to quantify cerebral blood flow velocity (CBFV). Four of the TCD studies 
were performed with patients, such as those with hypertension, obstructive 
sleep apnea (OSA), sub-arachnoid haemorrhage (SAH) and patients 
undergoing carotid artery angioplasty (CAA).  
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In total, 544 subjects participated in the reviewed studies, 317 healthy 
volunteers and 174 patients. The recorded features were different for the 
two methods; accordingly two separate spreadsheets were used, one for the 
fMRI studies and one for the TCD studies (Appendix 1). The MRI studies 
database included 26 columns and the TCD database included 19 columns. 
Because of the long columns and to show the data in more coherent way, 
separate tables were generated for the healthy control studies and the 
patient data (Appendix 1).   
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Figure 3 Chart of search results (PRISMA statement) 
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2.4 Methods to quantify CA metrics 
2.4.1 Magnetic resonance imaging (MRI) studies 
Functional MRI is a fast non invasive technique that has sufficient spatial and 
temporal resolution to allow for measuring CA metrics [114]. 19 of the reviewed 
studies used different MRI sequences at two different field strengths, 3T (13 studies) 
and 1.5T (6 studies). Different sequences were used to quantify the haemodynamic 
metrics such as BOLD, ASL, T2*, and PC MRI. Five studies estimated the percentage 
signal change (PSC) from the magnitude of the BOLD images, to anticipate the 
underlying vascular response [18, 28, 93, 114, 115].  
Within these studies different physiological stimulations were used to induce dynamic 
changes in cerebral blood flow. The diagram in Figure 4 shows the BP-intervention 
method for each group of studies with the references stated in numbers.  
Magon et al (2009) compared different breath-hold periods to induce dCA changes. 
Their results show that PSC and volume changes are highly dependent on the 
duration of BH. In their experiment higher signal changes were observed for the 21-
second BH duration compared to the 9-second and 15-second BH durations [114]. 
These results concur with the results of Murphy et al¶V(2011) study, in which a 20-
second BH was used to induce a cerebrovascular response to hypercapnia. They 
suggested that considering the individual end tidal CO2 (ETCO2) responses to BH in 
the analysis would increase the accuracy of the measured vascular responses, and 
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consequently more statistically active voxels would be achieved in the group level 
analysis [18]. These two studies [18, 114] investigated the effects of breath-hold 
duration on the PSC of the BOLD magnitude. Meanwhile, Thomason et al (2008) 
established a method to test the effects of inspiration depth on the underlying BOLD 
signal by giving visual feedback to the individuals during the breath hold task. 
Different responses were observed in the BOLD signal amplitude changes according 
to the depth of inspiration. This indicates the effects of the depth of inspiration on 
the cerebrovascular response [115].  
Blood oxygen level dependent (BOLD) signal change is a sensitive tool for mapping 
the cerebrovascular response to hypo and hypercapnia. However, qualitative 
interpretation of the BOLD amplitude is complex, because it depends on more than 
one hemodynamic parameter such as CBF, CBV, hematocrit and CMRO2.  
Quantitative CBF maps can be obtained using ASL functional magnetic resonance 
imaging. Arterial spin labeling fMRI uses magnetically labelled water protons as an 
endogenous tracer. Four studies included in this review used ASL derived 
quantitative flow maps to estimate dCA metrics [8, 19, 116, 117].  
Noth et al (2008) determined CBF maps with pulsed ASL in 19 healthy subjects under 
baseline, hypoxia and hypercapnia conditions. There was a statistically significant 
(5.8 s 0.9%) increase in GM-CBF per 1 mmHg increase in partial pressure of CO2. 
Maps of CVR showed high intra-subject variability to hypoxia but less variability to 
hypercapnia [19] 
Bulte et al (2007) used pulsed ASL interleaved with Gradient Echo echo-planner 
imaging (EPI) BOLD to estimate CBV changes. They used epochs of hyperoxia as an 
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endogenous contrast media.  The results showed regional heterogeneity in the CBV 
response (Global CBV 3.77± 1.05%, GM 3.93±0.90%, WM 2.52±0.78% ml/100 
gm.) [117]. The complete non-invasiveness of ASL makes it very suitable for 
perfusion studies of healthy volunteers and patient groups requiring repetitive follow-
ups. The only draw back of ASL is the low signal to noise ratio (SNR), which makes 
averaging necessary, and thus good cooperation from subjects is essential. Further, 
ASL has limited temporal resolution that may restrict the application of this method 
to estimate dCA metrics.   
Two of the studies used absolute CBF and CBV values obtained by means of phase 
contrast magnetic resonance angiography PC MRI [74, 98]. This is a contrast free 
technique that allows non invasive volumetric measures in the brain. De Boorder et 
al (2012) combined a BH test with 2D PC MRI, while Meckles et al (2004) observed 
the spontaneous oscillations in the systolic-diastolic phases of the cardiac cycle. The 
former study validated the BH test as an applicable non invasive method for 
stimulating physiological changes in the cerebral circulation, which is concurrent with 
five other studies that used the same physiological stimulation but different 
sequences [15, 18, 94, 98, 114, 115]. The latter study compared intracranial velocity 
measures from 4D PC MRI with TCD, TCCD and 2D PC MRI [74, 98]. In their results, 
the CBFV measures from 4D PC MRI were consistent with other reference modalities, 
foremost with TCD. There was mild vessel diameter-dependent under- or over-
estimation of velocities in smaller (MCA) and larger sized arteries (BA and ICA), 
respectively. This might be an effect of spatiotemporal averaging [74].  
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Figure 4Methods to simulate dynamic cerebral auto regulation 
TCD=Trans-cranial Doppler ultrasound, MRI=magnetic resonance imaging, TCR=thigh cuff release, IHGT=isometric hand 
grip, GB=ganglionic blockade, BHT=breath hold test. References stated in numbers 
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2.4.2 Trans-cranial Doppler ultrasound studies (TCD) 
Intra cranial cerebral blood flow velocity (CBFV) measurement obtained by 
TCD is a validated surrogate for CBF to estimate the dynamics of dCA [6]. 
Usually a 2MHz trans-cranial Doppler probe is used to illuminate the cerebral 
arteries through anatomical windows (Appendix 1). 15 studies included in this 
synthesis used TCD to measure the CBFV of major cerebral arteries (MCA, 
ACA, ICA, VA and BA). Quantitative comparison of the absolute CBFV values 
was not applicable because of the different interventions and excessive 
heterogeneous read-outs.  
The flexibility in the hemodynamic perturbation methods is an advantage of 
TCD over MRI studies. Different physiological interventions were used to 
stimulate ABP. Blood pressure stimulations such as carotid artery short 
compression, and standing-squatting test are not applicable in the MR scanner 
[14, 118]. Despite the applicability of the isometric hand grip test (IHGT) as 
a validated ABP stimulator [119, 120], no studies could be retrieved from the 
database that had used this method to measure cerebral autoregulation in an 
MRI scanner. However, four TCD studies obtained comparative results using 
IHGT as an ABP stimulator [37, 121, 122] (Figure 4) 
Thirteen out of fifteen studies measured CBFV only in the middle cerebral 
artery (MCA). Willie et al (2012) quantified and compared the CBFV in the 
posterior cerebral artery (PCA), vertebral artery (VA), ICA, and MCA.  They 
observed different vessel responses to hypercapnia. The measured response 
was higher for the VA and ICA than the other vessels (50% and 25%, 
respectively) [123]. These results indicate vessel diameter dependence of the 
CA response. 
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 Hartwich et al (2010) obtained measures from the left anterior cerebral artery 
(ACA) in response to IHGT using TCD. They also measured the pial-artery 
pulsation and sub arachnoid space width (SAS) using near-infrared trans 
illumination/backscattering Sounding (NIR-T/BSS). IHGT induced a significant 
increase in Pial-artery resistance, a simultaneous decrease in the SAS width, 
but no change in the CBFV [121].  
Ikemura et al (2012), in addition to the TCD measures of MCA blood flow 
velocity, quantified the superior temporal retinal arteries (STRA), inferior 
temporal retinal artery (ITRA), and retinal choroidal vasculature (RCV) using 
laser speckle flowmetry. They used IHGT and the cold pressor test (CPT) to 
stimulate dynamic autoregulation. Their results show an increase in the RCV 
blood flow velocity, more than other arteries, which indicates poor 
autoregulation performance in the mentioned vasculature [122]. 
Several methods have been used to estimate the dynamics of cerebral 
autoregulation from CBFV measures of TCD. One of these is cerebrovascular 
conductance (CVC), which represents the ratio of the mean blood flow velocity 
to the mean arterial blood pressure (CVC=MCBFV/MABP) [37, 118, 121-124]. 
Another method is transfer function analysis (TFA) using ABP and CBFV as the 
input and output values, respectively [111, 125]. An autoregulatory index 
(ARI) scaling from 0-9 (0= absence of CA -9=best CA) was used to model the 
hemodynamic changes in three studies [9, 10, 22]. Panerai et al (2013) 
observed a highly significant inter-hemisphere correlation for continuous ARI. 
These TCD measures from different vessels classify the method as a sensitive 
tool to model the vascular reactivity response. Measuring the flow velocity in 
different vessels could be used to estimate dCA metrics in different cerebral 
territories. 
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2.5 Cerebral autoregulation indices  
Routine evaluation of CA in clinical practice requires objective and reliable indices 
that can provide a continuous measure of cerebrovascular reactivity or other indices 
of CBF in the presence of fluctuation in the mean ABP or CPP. Autoregulation indices 
quantify the relationship between the corresponding CBF and BP. Different indices 
have been used in clinical and research settings (Table 1). Some of these methods 
approach the BP-CBF relationship as if it were linear. It should be noted that more 
complex mathematical models have been developed that allow for non-linear 
dynamics [126-129] Table 1 summarizes the list of indices used to estimate 
dynamics of cerebral autoregulation.  
Linear system analysis facilitates the examination of the transfer function between 
MABP and CBFV changes as a measure of autoregulation. It is calculated as the 
IXQFWLRQ RI JDLQ SKDVH DQG FRKHUHQFH EHWZHHQ WKHVH WZR YDULDEOHV XVLQJ :HOFK¶V
method. The impulse response function is calculated as the inverse Fourier 
transformation of the transfer function. This enables the estimation of transient 
changes in CBFV during BP fluctuations [130]. The transfer function of autoregulation 
indices can quantify the extent to which the BP-input signal is reflected in the CBFV-
output signal.   
The autoregulatory index reflects the changes in CVR per second in relation to the 
changes in ABP. The actual CBFV curve is compared to a computer based model CBFV 
curve, which assumes that the CBFV passively follows the course of ABP. For example, 
if the actual CBFV curve from the given test fits this computer model curve, the ARI 
will be 0.  A scale from 0 (no autoregulation) to 9 (perfect autoregulation) is used to 
model the autoregulation function. An ARI of 0 indicates that CBFV is passively follows 
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BP changes, and an ARI grade 9 indicates that CBFV recovers much faster than BP 
[34]. The autoregulation index can grade the autoregulation by estimating the impulse 
response function after transient impulse-like BP changes [125].  
Principal dynamic modelling (PDM) obtains reliable dynamic non-linear models of the 
causal relationship between two input signals; MABP and ETCO2 time series and the 
output signal of the mean CBFV [127]. This model is a variant of the Volterra based 
approach for modelling a non-linear relationship between two signals [128]. Principal 
dynamic modelling allows estimation of dynamic changes from short data-records and 
also facilitates a physiological interpretation of the obtained model. The 2nd order 
Volterra, function between two inputs, represents the qualitative pattern by which the 
two inputs interact in order to influence the output. There have been indications that 
the dynamic characteristics of the autoregulation process might vary over time due to 
neural and metabolic factors [125]. Time-varying modelling of autoregulation allows 
quantitative understanding of the time varying characteristics of dynamic cerebral 
autoregulation, especially the temporal variation in the linear dynamics of CBF and 
CO2 vasomotor reactivity [126]. 
Rate of regulation (RoR) is defined as normalised changes in the cerebrovascular 
reactivity index (ǻ&95 according to BP changes in a particular time. The recovery time 
of CBFV after a BP event (decrease or increase) is taken as an estimated parameter 
for the dCA efficiency [6]. This rate shows how the functional response changes over 
time.  
 
 ൌ ȟȀȟȟ  
Linear systems can be described in the time or frequency domain [127]. The frequency 
domain type of analysis describes the relationship between CBFV and BP with respect 
to frequency [130]. The rate of regulation describes the analysis of the CBFV-BP 
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relationship with respect to time. The signal value is known at various discrete time 
points and the time domain graph shows how this signal changes over time. This type 
of analysis is used in the current study to estimate the rate of BOLD signal recovery 
after a fast BP-decrease induced by the sudden release of inflated thigh-cuffs. 
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Table 1 Summary of the autoregulation indices used to estimate dCA  
 
CBFV cerebral blood flow velocity, CVR cerebrovascular reactivity, ABP arterial blood 
pressure, MAP mean arterial blood pressure, PECO2, partial pressure of CO2
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2.6 Discussion 
Despite the wide range of non invasive physiological diagnostic tools 
developed to assess CA, the definition of a gold-standard method to measure 
CA is still missing. By a gold-standard method we mean a method that 
provides satisfactory temporal and spatial resolution in addition to ease of 
access. The gold standard method should be able to be used in research and 
on a daily clinical basis in both healthy and patient populations.  
It might not be possible to provide all of the standard properties in a single 
tool, but approaching a balance in the accessibility and accuracy of the 
diagnostic tool is the main aim. The aim of this study was to explore possible 
bases and directions for developing a simple diagnostic tool to quantify 
cerebral autoregulation. 
2.6.1 Non invasive physiological method to measure CA 
Answering such a question regarding the best method to measure CA might 
be beyond the limits of this review. But it is possible to discuss the existing 
literature in the light of the available methods, keeping in mind a few crucial 
fundaments, such as the effectiveness of the method, and its safety, 
availability and applicability in patient populations. Thus far in the literature, 
TCD is the most commonly used technique to measure CA, because of the 
availability and portable nature of the device, which allows bedside 
examination.  One of the main possible limitations of TCD is spatial resolution. 
The anatomical windows restrict the vessel illumination of some major 
cerebral arteries.  However, with the recent advances in the fMRI, it is possible 
to obtain separate CBF and CBV measures with high spatial and temporal 
resolution. These individual measures obtained from fMRI classify it as a 
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reliable diagnostic tool to estimate CA. Beat-to-beat measurement of dCA 
metric is clinically valuable in patients with autonomic failure and 
cerebrovascular diseases [74]. Cardiac gated 2D phase contrast MR 
angiography is currently the only promising technique that can obtain beat-
to-beat cerebral flow volumetric measures [98].  
A combination of a simple physiological ABP stimulation with fMRI measures 
is necessary in both research and clinical settings. Yet, optimization of this 
physiological method should be through quantitative and qualitative 
description. Continuous ABP measures within the MRI scanner would provide 
better interpretation of the physiological aspects of CA metrics.  
2.6.2 Consistency of CA metrics 
The consistency within the field of measuring CA is complex, because of lack 
of a standardized method. Very few studies can be compared because the 
studies available are using different methods to estimate dCA metrics.  In 
order to examine the consistency of the studies, two types of comparison will 
be deliberated: first, an intra-method comparison (MRI and MRI, or TCD and 
TCD); and second, an inter-method comparison (MRI and TCD).  
Within the fMRI studies that used BOLD signal amplitude to assess dCA, 
different methods were used to induce dynamic changes such as hypercapnia 
[93, 117, 131, 132], BH [133], and TCR [22]. Despite different physiological 
interventions, six of the MRI studies obtained comparable values for the 
percentage BOLD signal change, and the results were consistent for regional 
GM and WM measures (Appendix 1-Tables 21, 22, and 23) [22, 93, 117, 131-
133]. Three studies indicated regional differences in the cerebrovascular 
response within the cerebral cortex [22, 93, 117]. It is important to notice 
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that the strategy and methodologies applied were not the same across all 
studies.  
The reliability within the TCD studies can be observed by comparing the 
absolute CBFV measures. Most of the studies obtained a relatively consistent 
ratio of CBFV-variability despite the diverse ABP fluctuating interventions [9, 
10, 99, 111, 123, 134]. Four studies obtained none or little change in CVCi 
using a handgrip and the cold pressor test (CPT) to stimulate dynamic changes 
[37, 121, 122, 135].  
 
2.6.3 Regional heterogeneity 
The anatomical coverage depends mainly on the method of measurement. 
Most of the TCD studies focused on MCA measures because of the reliable 
accessibility through the temporal window. However, some studies acquired 
repeatable measures from different cerebral vessels using TCD. Wszedybyl et 
al (2012) calibrated blood flow measures from the ACA using TCD [136].Willie 
et al (2012) used near-concurrent vascular ultrasound measures of flow 
through the ICA and VA, and blood velocities in the PCA and MCA [123]. Their 
results showed larger reactivity in VA compared to other vessels in response 
to hypocapnia, but similar reactivity for hypercapnia in all vessels. Meanwhile, 
the MCA and PCA velocity measures showed lower estimates than the ICA and 
VA. Their findings suggest the underestimation of TCD measures in smaller 
diameter arteries, which is concurrent with the results from the study by 
Meckel et al (2012) [74]. Furthermore, their results of regional heterogeneity 
of blood flow regulation in the brainstem and cortex support the results of 
Horsfield et al (2013) [22], who showed regional CVR heterogeneity in an 
fMRI study.  
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The main debate on regional coverage can be addressed in the MRI studies. 
There are some consistent recorded regional heterogeneities of 
cerebrovascular response in between grey matter (GM) and white matter 
(WM), and also in between cerebellum and cerebral cortex [22, 93, 117, 132] 
(Appendix 1-Tables 21, 22, and 23). The general agreement, over the 
recorded larger signal drop being more in GM than in WM, is sensible because 
of the higher metabolic demand of GM.  Nevertheless, in Bright et al (2009), 
different regions within cortical GM were compared for the BOLD signal 
intensity. The bilateral medial cortex reached a maximum signal intensity a 
few seconds earlier than the rest of the cortical GM [93]. Kassner et al (2010) 
compared ³ZLWKLQ-GD\´ DQG ³EHWZHHQ-GD\´ &95 UHSURGXFLELOLW\ DQGQRWLFHG
H[FHOOHQW³ZLWKLQ-GD\´&9R reproducibility in both GM and WM (ICC=0.92 and 
,&&  UHVSHFWLYHO\EXWH[FHOOHQW³EHWZHHQ-GD\´UHSURGXFLELOLW\RQO\ LQ
WM (ICC=0.66) [132]. Although these results might need further validation, 
they show the regional sensitivity of BOLD signal response to hypercapnia. 
In terms of regional heterogeneity of dCA metrics, there are few consistent 
results across TCD and MRI studies [22, 93, 117, 123].  The results of these 
studies show faster recovery in WM than GM, which may be related to the 
vascular density and vasodilatation. Furthermore, Bright el al¶V (2009) study 
showed consistent regional heterogeneity in the BOLD signal response timing 
to cued deep breathing and a periodic breath-hold test. The BOLD signal 
amplitude in parts of the basal ganglia, particularly the putamen and bilateral 
areas of the medial cortex, reached their maximum signal intensity change 
several seconds faster than GM [93]. Willie et al (2012) used CBFV measures 
from TCD to estimate the cerebral vaso reactivity in different vessels. The 
vertebral artery showed more reactivity to hypocapnia than ICA, MCA and 
PCA, while reactivity to hypercapnia was similar in all major arteries [123]. 
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In order to outline a stepwise intra-method and inter-method comparison a 
meta-analysis is more reliable; this is not feasible and therefore not included 
in this review. However, synthesis of the data in terms of average means, 
ranges and confidence intervals is not applicable because of the excessive 
heterogeneous data, the different interventions and/or different read-outs. 
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2.6.4 Interventions to fluctuate blood pressure 
Estimating the cerebrovascular reactivity response to rapid arterial blood 
pressure fluctuations is a convenient method for measuring CA metrics. High 
variability of MABP results in better estimation of the dCA measures [99]. A 
range of methods that fluctuate the systemic blood pressure can induce the 
dynamic response changes of autoregulation. But the safety and availability 
of these methods are restricted by many factors, such as the method of 
measurement and the VXEMHFW¶VFRPSOLDQFH Autoregulation performance is 
activated by a decrease or increase in the arterial blood pressure. However, 
the effectiveness of the decreased or increased BP on the cerebral blood 
flow regulation might be different. This is not addressed in the literature to 
the best of WKHDXWKRU¶Vknowledge. 
Another way to induce dynamic CA is by changing the partial pressures of 
respiratory gases. Several studies included in this review have used 
hyperoxia or hypercapnia to stimulate dynamic changes in the cerebral 
vasculature [18, 73, 93, 94, 98, 99, 114, 115, 117, 123, 131, 132, 134, 
137-139]. Different respiratory challenges were used to induce changes in 
the ETO2 and ETCO2, such as a gas mixture with a high CO2 concentration 
(4-8%), short periods of high O2 delivery (100%), and breath holding 
techniques (Figure 4). The respiratory challenge studies could be considered 
as relatively robust non invasive methods for inducing dynamic changes.  
Hypercapnia can induce a sufficient BOLD signal change and this can be 
acquired in a short period of time [94]. The spatial extent of the vasomotor 
response (VMR) to respiratory challenges can be improved by expressing 
the BOLD response as a percentage signal change using ETCO2 as a 
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regression value [18, 98]. Nevertheless, fast reproducible vasomotor 
response measures can also be obtained using a combination of PC MRI and 
breath-hold (BH) challenge [98]. There are few factors that affect BH test 
results. These can be classified as follows: first, technical factors such as the 
depth of respiration, the duration of BH and the phase of respiratory breath-
hold (expiratory or inspiratory); and second, physiological factors such as 
the baseline CBF and regional heterogeneity. The physiological aspects of 
the dynamic changes in response to hypercapnia are different from those of 
arterial blood pressure changes. Hence, comparing the effects of these two 
physiological triggers might enable a better understanding of the dCA 
performance. 
The next most frequently used method is thigh cuff release  (TCR). Four 
studies used this method (Figure 4). TCR is considered as a slightly 
uncomfortable experience for the subjects, but out of the 62 subjects who 
underwent this method to stimulate dynamic cerebral autoregulation (dCA), 
only one subject withdrew due to pain intolerance. The CBFV results 
obtained under the TCR influence are relatively consistent in all of the 
studies [17, 22, 99, 134]. Furthermore, Katsogridakis et al (2012) tried to 
increase the specificity and sensitivity of dCA measures by adding TCR to 
the hypercapnia method. In their results, combining the two methods 
improved the sensitivity and specificity of CA impairment diagnosis.  Area 
under the curve (AUC) increased from 0.746 to 0.859 (p=0.031) [99].  
Another method is the isometric handgrip test (IHGT). Although sufficient 
blood pressure change is obtained from IHGT [119, 120] and it is possible 
to use this in the MRI scanner, no studies that have used this method to 
stimulate dynamic cerebral autoregulation changes in the scanner could be 
retrieved from the database. On the other hand, four TCD studies used IHGT 
to stimulate MABP to measure the MCA velocity response changes (MCAv). 
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Three of these combined IHGT with the cold pressor test (CPT) [37, 122, 
135]. Vianna et al (2012) have observed a mild decrease in the 
cerebrovascular conductance index (CVCi) response to CPT, the rate of 
reduction was decreased by adding IHGT to the method [140]. Wszedybyl-
Winklewska et al (2012) used only IHGT to stimulate blood pressure and 
obtained a significant increase in the pial artery resistance, with a 
simultaneous decrease in the width of sub arachnoid space (SAS)[121]. 
IHGT might give sufficient perturbation in the systemic circulation to allow 
dynamic cerebral autoregulation activation.  
Although a combination of methods may give higher perturbation in the 
systemic circulation combining different methods should be performed 
carefully as pathways through which the dynamic changes are induced might 
be conflicted. The cerebral vascular adaptation that takes place in response 
could be altered or even blunted.  
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2.6.5  Limitations  
Measuring the dynamics of CA relies on the method of blood pressure 
fluctuation and the CBFV acquisition technique. Despite advances, the gold 
standard of assessment remains elusive and clinical practice is limited. In 
general, one of the challenges in measuring CA is the temporal pattern of 
the measurement method. Deoxyhaemoglobin accumulates over time in the 
cerebral circulation. It might interfere with the direction of the principal 
approach and disperse the absolute values. It is not possible to control the 
critical variables through a pre-defined time interval. At the same time, the 
cerebrovascular response is not instantaneous. The hemodynamic response 
function follows a stimulus by a few seconds. Therefore the stimulus interval 
should be considered carefully when attempting to induce dynamic changes. 
Cerebral autoregulation is frequency dependent; accordingly, the applied 
methods should assume the non-linear nature of autoregulation when trying 
to quantify the dynamic changes.  
MRI studies are limited by technical factors such as the signal to noise ratio 
(SNR), the resolution and spatial coverage. The physiological noise, which 
is corrected in most of the fMRI studies, could be used to obtain peat-to-
beat dCA measures.  
The main limitation of TCD measures is spatial resolution, which is restricted 
by anatomical windows. The tortuous arteries and angulations can be 
another restriction in velocity based TCD measures.  
Identifying the best method to measure dCA metrics requires a meta-
analysis study, to evaluate the measurement methods quantitatively as well 
as qualitatively. However, a quantitative analysis of the available 
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measurement techniques is not possible at this stage for the following 
reasons. First, meta-analysis calculates and compares the weighted average 
of common measures that are shared between studies. It is obvious from 
the studies included in this review that CA metrics are affected by inter- and 
intra-subject variability. Second, there is a lack of standardized 
measurement methods. Finally, the non-stationary nature of CA restricts the 
reliability of a longitudinal follow-up for the measured indices. 
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2.7 Conclusions and future directions 
The methodologies and applications of dCA assessment have been reviewed 
according to their reproducibility and consistency. Autoregulation is time and 
frequency dependent rather than a concrete value. There is very limited 
consistency within and between methods. Even so, few studies with 
consistent changes in CBF and CBV changes were identified. Regional 
heterogeneity between GM and WM and also the cortical and sub-cortical 
regions was consistent in a few studies regardless of the different acquisition 
methods applied.  
A standard physiological tool to measure autoregulation parameters is still 
under development. The majority of studies that have evaluated CA are 
proof of the concept while what is necessary is the development of standards 
for physiological interventions, haemodynamic sensitive imaging, and 
analysis methods.  A comparison of standardized methods would give more 
rigorous results. The development of fMRI studies with different analysis 
methods provided a better understanding of the physiological parameters of 
autoregulation. Arterial blood pressure variation provides a strong element 
for mapping the dCA pressure response. Studies that compare the methods 
of ABP perturbation are necessary in the field. The potential of MRI as a 
physiological diagnostic tool for CA may be improved by the application of a 
higher field of strength (7T), reliance on a more consistent physiological ABP 
fluctuation method, and the ongoing improvement of analysis methods.  
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Chapter 3 
3 Obtaining beat-to-beat Arterial Blood Pressure 
Measurements using Non invasive methods 
3.1 Background 
To study dynamic cerebral autoregulation, a step response change should 
be induced in the arterial BP to allow recording of the corresponding CBF 
changes [9]. Another method to induce a cerebrovascular response change 
as an index of CA is hypercapnia or hypocapnia. Changing the end tidal CO2 
(ETCO2) concentration has been used in several studies to induce dynamic 
responses [93, 94, 98, 109, 110]. Different respiratory challenges have 
been used for this purpose such as breath-hold and increasing the inhaled 
CO2 concentration (5%). Respiratory challenges are also associated with BP 
changes (The mechanism behind this process is discussed in Chapter one). 
Previous studies have successfully estimated CA changes using 
instantaneous recordings of CBFV and ABP step changes from TCD and 
Finapres (Finometer), respectively [6, 17, 22, 34]. The Finometer system is 
approved as a reliable non invasive ABP monitoring device. The reliability of 
Finapres ABP recordings has been examined previously by comparing the 
results with invasive arterial blood pressure measurements [141]. 
Nonetheless, in the current study, the CA assessment was to be undertaken 
using fMRI, an Finapres is not compatible with the magnetic field. Instead, 
the Caretaker device was used from the Biopac® system, which is an MR 
compatible plethysmographic device that can be used to monitor beat-to-
beat ABP measurements [142].  
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Several non invasive interventions were used to induce step changes in ABP. 
The reliability and consistency of these methods are controversial. The 
selection of the non invasive stimulus type depends on the patient group 
and also the compatibility with the CBF acquisition device.  This thesis 
examines two main types of non invasive autoregulatory-stimuli to be used 
in healthy volunteers. These include: thigh-cuff release (TCR), and 
respiratory challenges. The respiratory challenges consist of three different 
tests: deep-inspiratory breath-hold (iBH), non-inspiratory breath-hold (BH) 
and cued deep breathing (CDB). The physiological background of each 
method is discussed in Chapter 1. These methods were examined outside 
the scanner first to evaluate the feasibility and repeatability of each 
experiment. Before assessing each method for robustness and consistency, 
it was necessary to assess the feasibility of the recording device outside the 
scanner, to be used later as a reliable ABP acquisition tool in the scanner. 
For that reason we acquired instantaneous ABP recordings during TCR and 
BH using both devices, the Caretaker and Finometer. The BP response to 
the CDB test was recorded using only the Finometer because during the data 
acquisition time the Caretaker system was not available due to some 
technical issues. Figure 5 shows a graphic summary for the pilot studies and 
the measurement devices used in this chapter.  
During the study to develop non invasive BP measurement methods, 
another two methods were used in five healthy subjects to induce BP 
fluctuation, IHGT and leg elevation.  Blood pressure fluctuation could not be 
obtained from either of these two methods; therefore they were excluded 
from the method development studies (Data is not shown).  
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Figure 5 Summary of non invasive BP fluctuation methods 
Diagram shows a summary of the measurement devices used outside the 
scanner. CDB cued deep breath, iBH deep-inspiratory breath-hold test, BH 
non-inspiratory breath-hold test, BP blood pressure 
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3.2 Plethysmographic arterial blood pressure recording devices 
3.2.1 MR compatible arterial blood pressure monitoring device (NIBP-
MRI/Caretaker; Biopac®) 
The Caretaker system (Empirical technologies Corporation, Charlottesville, 
VA) estimates arterial blood pressure on the finger (Figure 6) by analysing 
the amplitudinal and temporal behaviour of the component pulses that 
constitute the peripheral arterial pulse [142]. The Caretaker effectively 
records the arterial blood pressure through reconstructing the estimated 
peripheral arterial pressure. It is MR compatible, which allows for obtaining 
the continuous arterial blood pressure estimation at any field strength 
(http://www.biopac.com/Noninvasive-Blood-Pressure-MRI). 
The sampling rate depends on the heart rate (HR). Like other 
plethysmographic devices, the Caretaker records the BP value at the 
beginning of each cardiac cycle (heart beat). This might be a limitation for 
large sample size studies, particularly for populations with a very wide range 
of variable heart rates.  
Tracking and quantifying the arterial component pulses is a challenging task 
and the algorithms that perform this task are still being refined. Under 
optimum conditions the acquisition process still experiences intermittent 
drop-outs [143]. 
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3.2.2 Non invasive Continuous Arterial Blood Pressure Monitoring Device 
from (Finometer ®) 
By clamping an artery, the Trans mural pressure (the pressure difference 
across arterial wall) is set to zero. When the artery is fixed at its unstressed 
and non-zero diameter, the intra and extra- arterial pressure are parallel; 
this is referred to as the ³3HQD]PHWKRG´ [144]. The Finometer uses the 
Penaz method to indirectly measure arterial pressure from the finger [145]. 
It is a reliable alternative to invasive arterial pressure monitoring (Figure 7) 
[146]. The beat-to-beat ABP measures from the Finometer and the CBF 
measures from the TCD have been used to estimate CA metrics [17].  
The accuracy of the device has been evaluated for clinical and experimental 
settings [147, 148]. In addition to BP, it measures several other 
physiological entities such as cardiac output (CO), stroke volume (SV), and 
heart rate (HR). The BP recordings focus on the absolute measurement of 
the systolic and diastolic measures and their variability [147].  
The recorded data is susceptible to technical and physiological artefacts. The 
physiological confounds are mainly due to changing posture, sneezing, 
coughing and other normal physical reflexes [147, 148]. The servo-control 
system that inflates the finger cuffs maintains sufficient pressure in the cuffs 
according to the blood volume available in the peripheral artery. This is 
controlled by a physical algorithm [145]. The physical auto-calibration 
allows long term recordings of BP. It corrects for changes in the stress and 
tone of smooth muscles in the arterial wall that occur during recording.  The 
main limitation of using the Finometer in this experiment was the non-MR 
compatibility of the device.  
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Figure 6 Caretaker finger cuff, port and graphical user interface GUI 
 
Figure 7 Finometer finger cuff and device  
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3.2.3 Technical issues 
At the beginning of this study the Caretaker device was suffering from 
severe technical issues.  The BP measurement was crucial for the dCA 
metrics. Therefore, at the beginning of this pilot study the BP measures were 
obtained manually at an interval of 1 minute using a (OMRON HEM-790IT) 
sphygmomanometer (data not shown). The Caretaker device had been 
returned to the manufacturer because of some technical issues. The main 
issue was a rupture in the one-way control valve that controls the coupling 
pressure between the NIBP port and the finger cuff. Maintaining the coupling 
pressure at 40-50 mmHg is necessary in order to receive a good signal from 
the device. Another BP recording problem was the GUI control system, which 
suffered from frequent drop-outs during the BP recordings. Even though the 
software was updated to the latest version, this problem still occurred 
sometimes. As I noticed that the drop-outs often occurred when the saving 
results function was activated before the calibration process, the BP data 
recorded by the Caretaker were shared with the Biopac system support team 
to check the quality of the data. Another problem associated with the 
Caretaker BP recording was the long connecting tube that controls the finger 
cuffs from the control room to the scanner that has lead to loosening of the 
cuff pressure and required multiple calibrations within a scanning session. 
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3.3 Monitoring beat-to-beat arterial blood pressure measures 
3.3.1 Methods and materials 
 
Five healthy adult subjects were recruited for the cued deep breath (CDB) 
study (22-31 years; 2 females). Another three healthy volunteers (22-31; 
1 male) were recruited for the TCR and BH test. Table 2 summarizes the 
number of healthy volunteers recruited for each protocol. The thigh-cuff 
release and breath-hold test were performed during the same session with 
the same volunteers. The BH test was implemented first, followed by the 
TCR challenge; ten minutes rest was allowed between the protocols. This 
study was conducted according to the approved ethics of Nottingham ethics 
committee for developing novel MRI techniques (appendix 2). 
The subjects were positioned comfortably on a medical couch. 
Instantaneous BP recordings from both devices were acquired at a sampling 
rate of 100Hz. Each device cuff was attached to the middle finger of the 
contralateral hand (Figure 6 and 7). For all of the pilot studies outside the 
scanner, the author performed the application of the devices, the subject 
preparation, the data acquisition, the study observation, and the data 
analysis.  
The Finometer device was calibrated automatically at the beginning of each 
experiment and after changing posture or replacing the finger-cuffs. The 
starting and stopping points for each experiment were marked manually for 
both devices, which led to a gap of a few seconds. To compensate for the 
timing latency, the Caretaker device was always marked before the 
Finometer, because the latter is provided with a single key marking function 
that may limit the time gap to one second or less. The recorded BP data was 
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marked for the time of each stimulus (BH or TCR). This helped to separate 
the artefactual pressure curves from the stimuli induced BP fluctuations.  
The blood pressure was manually calibrated for the Caretaker system. After 
establishing Bluetooth communication between the power supply and the 
GUI control system, the brachial artery blood pressure was used as a 
reference for calibration. This was measured using a (OMRON HEM-790IT) 
sphygmomanometer.  
The Caretaker data was observed and collected using graphical user 
interface (GUI) control software (vs. 4.1.0 - 4/20/2012) (Figure 6). This 
allows for controlling and maintaining the pressure in the sensor pad through 
a single pathway valve system.  
During the TCR test, large inflatable cuffs (Model C22, Hokanson Inc., USA) 
were wrapped around each thigh. The inflation of the thigh-cuffs was started 
after securing a sufficient recording signal from both devices. The thigh-
cuffs were inflated to at least 20 mmHg above the systolic BP and this was 
maintained for three minutes. A one-minute recovery period was recorded 
after the sudden release of the thigh-cuffs. A custom-made wooden footrest 
was used to support the leg against the deflation manoeuvre, this was 
provided by a study collaborator (Mark Horsfield) from the University of 
Leicester. The footrest allows subjects to brace their feet at a comfortable 
knee flexion angle and also prevents motion artefact during deflation.  At 
the end of the experiment, all of the volunteers were asked to give feedback 
about the TCR experiment and rate any discomfort or pain they had 
experienced during the cuff inflation and/or deflation.  
During the breath hold test the instructions for breath hold and release were 
delivered using the VXEMHFW¶VYLVXDOLQVSHFWLRQof a sequential power point 
preseQWDWLRQRQD¶¶+3ODSWRSA four-minute recording was obtained 
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for each protocol, in which three 20s breath holds were performed with 30s 
rest in between. The instruction was given at the beginning of each iBH, to 
take the deepest inspiration and then hold the breath. For the BH test, the 
cessation of breath was performed at any phase of the respiratory cycle that 
corresponds to the timing of breath hold without any effort to change the 
phase of respiration. To confirm a consistent breath hold test, the cessation 
of breathing was observed carefully by the author throughout the 
experiment. This was further verified by comparing the HR disparity during 
the apnoeic phases.  
The transfer function between the CDB test and BP was estimated by having 
the subject perform a series of 2 second deep inhalations and 2 second 
exhalations interleaved with 60 seconds of normal breathing. The cued deep 
breaths were repeated six times in one recording session; the overall 
recording time was seven minutes (Figure 8). The beat-to-beat 
systolic/diastolic compartments of BP were measured using the Finometer 
device.  
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Blood pressure 
fluctuating method 
Number of healthy  volunteers  participated in each method  
Caretaker 
BP 
measurement  
Finometer 
BP 
measurement  
MRI  
(BOLD) sequence 
MR-angiography 
(4D PC) sequence 
TCR Ɍ ? Ɍ ? 
 æ 6 
( 1* excluded) Non 
iBH Ɍ ? Ɍ ?  æ6 (2**excluded) Ɏ ? 
BH Ɍ ? Ɍ ? Non Ɏ ? 
CDB ѕ ? ѕ ? Non Non 
 
 
Table2 Summary of the volunteers who participated in each protocol. TCR, Thigh-cuff 
release, iBH, deep-inspiratory breath-hold test. BH, non-inspiratory breath-hold test. CDB, 
cued deep-breathing. BOLD, Blood oxygen level dependent MRI, 4D PC, Time resolved 
Phase-contrast MR angiography. 
Matching symbols signified by the number of volunteers represent identical subjects.  
* Results for one TCR were excluded because of a severe motion artefact present in both scans.  
** Results of two iBH were excluded because different scanning parameters were used (Time of 
repetition of 500 ms and 1000 ms) 
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Figure 8:Schematic representation of cued deep breathing test (CDB) and 
observed BP response. 
The top panel shows the sequential presentation of respiratory 
performances during CDB. 
The lower panel shows the average recorded MAP during CDB (averaged for 
five subjects) 
  
Time in heart beats  
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3.3.2 Data Analysis 
The Finometer data was transferred to digital format using (Beat scope 1.1a) 
software (www.adinstruments.com/products/beatscope). The functional 
marks that defined the starting and stopping points were selected and then 
exported after reformatting the (beat) files to text files. The data were saved 
in Excel spread sheets for further processing.  
The caretaker data were saved in ASCII format. The data were transferred 
to text files to be processed later into Excel format. During the data 
acquisition the Caretaker device recorded the following parameters inter-
beat interval, systole, diastole, cardiac output (CO), and heart rate (HR), as 
well as the parameters that the algorithm calculates. The selected time 
points (markings) throughout the experiment (time of inflation and 
deflation) were applied to the recorded BP measures (Appendix 3 contains 
the output file formats and relevant information). The acquired data were 
filtered manually using Microsoft Excel to remove any zero readings and 
drifts. This was performed by applying a filter to remove any zero values 
from the data. The mean arterial blood pressure (MAP), which is the average 
blood pressure during one complete cardiac cycle, was calculated from the 
systolic and diastolic compartments of arterial blood pressure. This was 
compared to the brachial artery MAP measurements acquired at the 
beginning and end of the experiment to estimate the reliability of the 
quantitative readings from the Caretaker.  
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The MAP was calculated using this formula  
ሺሻ ൌ  ? ൈ ܦ݅ܽݏ݋ݐ݈݁ሺ݉݉ܪ݃ሻ ൅ ܵݕݏݐ݋݈݁ሺ݉݉ܪ݃ሻ ?  
 
Equation 1: In which MAP is the mean arterial BP, Systole is systolic part of 
BP in mmHg and Diastole is diastolic part of BP in mmHg [149] 
 
The sampling rate for all devices that operate using the Penaz method or 
arterial clamping depends on the heart rate. In other words, a BP reading is 
recorded at the beginning of each cardiac cycle from both devices. 
Therefore, it was possible to compare the data between the devices. 
The time point at which the minimum BP drop occurred after each stimulus 
was visually identified. The MAP for each subject and each method at the 
baseline was calculated according to equation 1. By definition, the recovery 
of BP is equal to the baseline BP before the stimulation, and this was 
standardized to detect the recovery BP for all of the BP fluctuating methods. 
The average MAP for three subjects was compared to show the step changes 
measured with each device for the TCR, BH and iBH methods. The 
descriptive statistics were performed using a statistics package for the social 
sciences (SPSS v.22). An unpaired student t test was used to compare the 
means.  
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3.3.3 Thigh-cuff release method 
x Results 
During the pre-MRI TCR protocol, all of the subjects (n=3) showed a distinct 
BP drop after the thigh cuff-deflation. All of the subjects tolerated the test 
and their rating for the discomfort level was minor to moderate. The MAP 
for the three cases measured with the Caretaker and Finometer were 
relatively close and comparable to the brachial artery MAP measures 
measured with the arm-cuff sphygmomanometer  (Table 3).  Table 4 
summarizes the results averaged over the three TCR tests. The BP drop after 
TCR was deeper for the Caretaker measurements than for the Finometer 
(Caretaker 58±8 mmHg, Finometer 70±1 mmHg; mean±SD). The 
percentage BP decrease after thigh-cuff deflation was (29±1.3%) and 
(20±0.5%) for the Caretaker and Finometer, respectively.  However the 
two-tailed t-test was not statistically significant for the two values (P=0.3). 
Both devices were able to represent the fast BP±drop after the deflation and 
the post-stimulus recovery (Figure 9). The average recovery time for the BP 
to re-align to the baseline after the drop was (12-25) and (15-22) heart 
beats for the Caretaker and Finometer, respectively.   
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  Figure 9: Blood pressure (BP) response curve to thigh-cuff release (TCR) 
method 
(32 years; male subject) shows the systolic (Sys) and diastolic (DIA) 
arterial BP measures recorded simultaneously, measured by the Caretaker 
(top panel) and the Finometer (lower panel). The pink bar indicates the 
time of thigh-cuff release.
Time in heart beats  
Time in heart beats  
Movement artefacts  
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Table 3: Mean arterial blood pressure measures (MAP) at the baseline from 
the three devices (Omron-HEM, Caretaker, and Finometer) 
 
 
 
Table 4 MAP measures from the Caretaker and Finometer devices at 
different time points after cuff-deflation 
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x Discussion 
This experiment shows that the Caretaker and Finometer can both track BP 
changes over very short periods of time (<second). The MAP acquired at 
different time points after the release of the thigh-cuff was repeatable across 
the devices and subjects. The Caretaker derived MAP measures were slightly 
higher than the Finometer MAP measures (1-3 mmHg). This might be due 
to the over-sensitivity of the Caretaker device to movement artefacts and 
changes of posture (Figure 9). Furthermore, the Caretaker finger cuffs are 
single layered; therefore they should be applied with caution to avoid extra 
tight application, which can lead to higher readings.  On the other hand, the 
Finometer finger cuffs are double layered and less vulnerable to false 
readings. This can be seen in our data, where the MAP measures show less 
variability in the Finometer recordings than in the Caretaker readings (Figure 
9). 
The Caretaker Device does not require frequent re-calibration as long as 
there are no changes in the VXEMHFW¶VSRVWXUHDQGWKHSRVLWLRQRIWKHFXII
The algorithm has to detect and analyse each heartbeat. Therefore the 
Caretaker data is more prone to physiological noise interference, such as 
coughing and sneezing. Even normal tone speaking affects the results of the 
ABP measures. The main cause of a poor signal from the Caretaker is 
inadequate coupling pressure between the device and the finger-FXIIV
3RRUO\SHUIXVHGDQGFROGILQJHUVDUHRWKHUVRXUFHVRIDUWHIDFW. 
The Caretaker device recorded deeper BP-drops in response to a sudden 
release of the thigh-cuffs compared to the Finometer but the difference was 
not statistically significant (p= 0.3). 
The Caretaker and the Finometer were both able to track BP changes over 
short periods of time. The MAP readings were reliable in comparison to the 
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brachial artery acquired MAP. The results of this experiment show reliable 
BP quantifications by the Caretaker device. However, the long connecting 
tube that connects the finger-cuff to the acquisition port in the MRI control 
room may affect the consistency of Caretaker measures inside the scanner.  
A pilot study would be necessary before using it for haemodynamically 
unstable patients in the scanner. The sudden release of the thigh-cuffs 
induces a fast BP drop with corresponding CBFV changes in the brain that 
can be used to measure dCA metrics in healthy subjects. This study included 
only a healthy population with normal range BP. Evaluating the reliability of 
the dCA diagnostic tool requires examination at high blood pressure levels 
and in patient populations [12].  
 
In conclusion, the results of this experiment suggest the feasibility of an MRI 
compatible NIBP- Caretaker device to track induced BP changes inside the 
scanner. 
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3.3.4 Inspiratory and non-inspiratory BH 
x Results 
For the three healthy volunteers, a total of nine iBH and eight BH were 
obtained (the BP recordings of one BH test were excluded because of severe 
movement artefact). An iBH of 20 seconds resulted in a transient increase 
in BP followed by a step-response decrease, while the BH resulted in a 
gradual increase in BP without any considerable decrease at the end of the 
breath-hold (Figure 10). The different BP-response curves to inspiratory and 
non-inspiratory breath-hold were detected after initial observation of a 
single subject. This was the main reason for comparing the deep inspiratory 
with the non-inspiratory breath-hold tests in this pilot study. There was a 
significant difference between the BP response to the iBH and BH 
(P=0.0015). The BP drop was (17±3%; mean±SD) from the baseline for 
the iBH. The BP increase was (20±0.5%) for the iBH and (20±1%) for the 
BH. Tables 5 and 6 show the results of the BP fluctuation for both the iBH 
and BH. The difference between the BP-increases for the iBH and BH were 
statistically not significant (P = 0.3). The BP increase from the baseline was 
~20% for both the iBH and BH. The BP response curves to the BH and iBH 
were consistent across repeats of the same experiment.   
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Table 5: mean arterial blood pressure (MAP) responses to 20-second deep-
inspiratory breath-hold (iBH) 
 
 
Table 6: mean arterial blood pressure (MAP) responses to 20-second non-
inspiratory breath-hold (BH) 
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A
 
 
B  
Figure 10 Mean arterial blood pressure (MAP) from Caretaker device 
 (31 years, male). A: during non-inspiratory breath-hold test B: during 
deep-inspiratory breath-hold test. The three BP effects were averaged for 
each experiment. The data is shown in Tables 5 and 6.  
  
Time in heart beats  
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x Discussion 
The transient cessation of breathing resulted in a BP change in both the iBH 
and BH tests. In all of the subjects the iBH resulted in a BP increase followed 
by a step response decrease, while the BH resulted in a gradual increase in 
BP. The BP increase was similar for both methods ~20%. The BP increase 
was in line with other study findings [105]. 
The iBH method results in a biphasic BP response, whereas the BH method 
results in a monophasic BP increase (Figure 10). This kind of fluctuation in 
BP response to the iBH method develops a sufficient gradient in the BP 
change from the minimum to the maximum BP levels, which could improve 
the stimulation of dCA changes.  
The difference in the BP response curve for the iBH and BH resembles the 
negative pressure that occurs in the thoracic cavity at the beginning of deep 
inspiration. This derives a transient pressure drop in the arterial tree. 
Maintaining BH for 20 seconds is associated with a sympathetic activation, 
which is derived from both the fear of suffocation and the efforts made to 
maintain a closed glottis against the urge for respiration [109]. This might 
be the cause of the BP increase associated with breath-holding technique.  
Breath-hold is a non invasive method that results in adequate BP fluctuation 
to induce dCA changes. The iBH and BH give different BP fluctuation curves. 
The BP-drop associated with iBH may improve the dCA activation in brain. 
The BP-curve response to iBH is more similar to the valsalva effect that has 
been used previously to induce dCA changes [150]. Monitoring the 
respiratory volumes with a Capnograph would be necessary to give a better 
insight into the associated ETCO2 changes. This is because ETCO2 is an 
indicator of the CO2 level in the blood, which is a potent vasodilator that 
affects haemodynamic metrics.  
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In conclusion, the BP change associated with iBH can induce sufficient BP 
fluctuation to improve the corresponding BOLD signal changes. This method 
will be taken forward by applying it in healthy volunteers to induce dCA in 
the scanner.   
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3.3.5 Cued Deep Breaths 
x Results 
Cued rhythmic deep inspirations induced a BP increase that is visually 
apparent in Figure 8. Table 7 shows the results of the BP records for the five 
healthy volunteers. The average BP increase in response to CDB for the five 
subjects was (10±5%; mean±SD).  The average baseline BP for the five 
cases was (84±2; mean±SD). The difference between the baseline and the 
CDB BP-peaks was statistically significant (p=0.01). The average MAP 
during the recovery period between the repeated CDB was (81±5; 
mean±SD).   
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Table 7: summary of mean arterial blood pressure (MAP) measures after 
cued deep breath test (CDB). 
Baseline is the MAP before the CDB performance, Recovery-MAP is the MAP 
after CDB performance, Peak is MAP during CDB. Percentage change is 
calculated from the baseline before CDB. 
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x Discussion 
Cued deep breathing induced a MAP change that was recorded using a 
Finometer beat-to-beat BP measurement. The CDB induced BP changes in 
all of the subjects (n=5). The average response was (10±5%; mean±SD), 
which is less than the BH-induced BP changes (~20%). Although the 
average BP response to CDB was less than for BH, the associated ETCO2 
change was enough to induce a BOLD signal change [93].  
The CDB induced transient hypocapnia that prompted a dCA reactivity 
response. Previously it has been shown that the depth of inspiration affects 
the BOLD response to BH [115]. This might also be a fundamental factor in 
the variability in the rate of BP response to CDB. In this study, the rate of 
BP response was variable from one subject to another (6-19%). Yet, the 
shape of the BP-peak responses was similar for recurrent CDB episodes 
(Figure 8).  
CDB could be a good alternative for situations where BH and other long-
term respiratory modification are not applicable to induce dCA changes. This 
study could be further ascertained with respiratory volume measurements 
to determine the possible merit of the methods described.  
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3.4 Conclusions 
The sudden release of inflated thigh-cuffs and respiratory challenges were 
used to induced BP changes in all of the subjects. The shape and amplitude 
of the induced BP modification was different across the methods. Table 8 
summarizes and compares the induced MAP changes for all of the methods. 
The inspiratory breath-hold test induced biphasic and the most robust MAP 
fluctuating response and hence it was selected for the fMRI respiratory 
challenge study.  
Both devices could track fast BP changes. The quantitative measures from 
the Caretaker and Finometer results were parallel. This indicates the 
feasibility of using the Caretaker as a reliable continuous BP monitoring 
device for the fMRI experiments. 
Based on the findings of these pilot studies, the TCR and iBH methods will 
be used in the MRI scanner to induce BP fluctuation in healthy volunteers to 
stimulate a CA response in the brain.  
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Table 8: Summarizing the percentage BP change-responses to non invasive 
arterial blood pressure fluctuating methods. 
TCR thigh cuff release, iBH deep inspiratory breath-hold, BH non-inspiratory 
breath-hold, CDB cued deep breath. Ï BP increase, Ð BP decrease 
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Chapter 4 
4 Using Physiological MRI to Estimate dCA Metrics 
4.1 Introduction 
The objectives of this chapter are: to examine the feasibility of estimating 
dCA metrics at 3T MRI scanner, using this in combination with two non 
invasive BP fluctuation methods that have been selected based on the pilot 
tests detailed in the previous chapter; and, to obtain beat-to-beat arterial 
blood pressure measures from the scanner for these two methods.  
The dynamics of the BOLD signal amplitude are dependent on changes in 
CBF, CBV and CMRO2 [6], as described in Chapter one. Furthermore, 
changes in these parameters induce corresponding changes in the BOLD 
signal amplitude. Rapid changes in systemic BP induce instantaneous CBF 
changes in the brain. Measuring the amplitude of such concurrent changes 
in the CBF and BP allows for estimation of the CA metrics.  
The sudden release of inflated thigh cuffs has been used to induce dynamic 
changes in the systemic BP [12]. The BP drop in response to the TCR method 
was examined in the previous chapter for healthy subjects outside the 
scanner, and a (29%) change in the MAP was obtained. Measuring the beat-
to-beat arterial pressure in response to the TCR inside the scanner provides 
a better understanding of the corresponding BOLD signal changes. This was 
examined in this chapter by concurrent measurement of the BP and BOLD 
signal amplitude at 3T MRI scanner.  
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Breath-hold is another method that induces a BOLD signal change [83]. The 
average MAP change in response to a 20 second breath-hold was about 
(20%). The transient hypercapnia associated with breath-hold results in a 
gradual increase in CO2 concentration [83]. In addition to the vasodilatory 
effect of increased CO2, the breath-hold method is also associated with 
systemic BP changes. Blood pressure change stimulates the autoregulation 
process of the brain in order to maintain a relatively constant CBF despite 
the increase or decrease in BP. The shape of the BP response curve was 
examined for different respiratory challenges in the previous chapter. The 
deep-inspiratory breath-hold (iBH) induced a biphasic BP response, which is 
more similar to the valsalva effect. This kind of BP step response could 
improve the dCA metrics [150].  
In this chapter, the dynamics of iBH BP correspondence in relation to the 
resultant BOLD signal change are examined. The methods, subject 
demographics, data acquisition and analysis methods are discussed first. 
After that, the specific results for each method are described. Finally, there 
is a general discussion and the limitations of the methods and applications 
are explained. 
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4.2 Methods and materials 
Six healthy volunteers with a mean age of 28±7 (age range 23-42 years, 2 
females) were recruited.  Each subject was scanned for two protocols, TCR 
and iBH, in the same scanning session (Table 2). The results for one subject 
for the TCR method were excluded because of a severe motion artefact in 
both scans (details of detection for a severe motion artefact are described 
in the data analysis session). The results of the iBH for two subjects were 
not included in the group analysis because of different acquisition 
parameters (Time of repetition TR, 500 ms and 1000 ms vs. standard 2000 
ms) (Appendix 4). This study has been approved by the Nottingham Ethics 
committee for the development and optimization of novel MRI techniques 
(B12012012A).  
All of the volunteers signed a MRI safety questionnaire and informed consent 
form (a copy of both can be found in Appendix 2).   The subjects were asked 
to refrain from consuming caffeine and alcohol for at least 12 hours before 
scanning. They were screened before the start of the experiment by the 
author for any respiratory disease that may affect or limit their performance 
in the respiratory challenge. Ten minutes rest was allowed after arriving at 
the MRI control room to allow the VXEMHFWV¶ BP to settle down. 
The brachial artery BP was measured using a (OMRON HEM-790IT) 
sphygmomanometer. The subjects were positioned comfortably in the 
scanner. All of the physiological recordings were acquired using respiratory 
bellows and a vector cardiogram by GE healthcare. The Caretaker finger cuff 
was attached to the middle finger between the proximal and distal inter 
phalangeal joints. The pulse oximeter finger pad was attached to the index 
finger of the contralateral hand. The respiratory band was wrapped around 
the chest just below the xyphoid process of the sternum at a full inspiratory 
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phase to allow for flexible expansion during the respiratory challenge. The 
instructions for the breath holding stimuli were presented on a projector 
screen and PowerPoint presentation. The subjects viewed the screen 
through a mirror attached to the RF coil placed approximately 10 cm away 
from their face.  For subjects with low visual acuity, MRI compatible 
correction glasses matching the degree and type of their visual impairment 
were provided. These special glasses are MRI compatible and designed to 
diminish the interference with the magnetic field. All of the settings and 
subject preparations were performed by the author and supervised by a 
specially trained MR scanner technician.  
A soft cushion pad was used to support the knee joint at a flexion angle of 
about 40° to add extra comfort and prevent movement during the scanning. 
For the TCR protocol this was replaced by the custom-made leg support, 
which is described in Chapter 3, to prevent movement during the thigh-cuff 
deflation maneuver.  
The author stood beyond the 300 Gaussian-line in the scanner to inflate and 
deflate the thigh-cuffs during the scanning session for the TCR protocol. 
Soundproof insulating headsets were applied to cancel out the noise form 
the scanner. The thigh-cuffs were inflated to 20 mmHg above the systolic 
BP level. The BOLD sequence acquisition was started immediately after the 
barometric pressure reader reached 20 mmHg above the systolic blood 
pressure. This was observed carefully and kept constant across all of the 
scanning sessions. 
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4.3 Data Acquisition 
All of the MRI data were acquired at 3T GE scanner (General electric, MR750 
3.0 T) and 32-channel head coil. After localizer and ASSET calibration, an 
anatomical axial FSPGR BRAVO sequence was acquired with the following 
parameters (TE 3.18 ms, TR 8.172 ms, Flip angle 12, acquisition matrix 
256×256, slice thickness 1mm, and FOV 240×240 mm). For the 
physiological MRI a T2* w, 2D GE EPI sequence was acquired with these 
scanning parameters (TR 2000ms, TE 35ms, Flip angle 77, FOV 240 ×240, 
Slice thickness 3.6mm). Overall 120 volumes were acquired during a four-
minute acquisition time. The time of repetition (TR) for the BOLD sequence 
was selected as 2000 ms to avoid short TRs that might interfere with the 
variability in the heart rate when inducing the BP changes. TR 2000ms was 
selected subsequent to a few pilot scans at different TRs (500ms and 1000 
ms). Reliable BOLD signal response results were achieved at 2000ms TR 
(Appendix 4). 
The BOLD sequence was repeated five times. The first time was a resting 
state BOLD with eyes closed. This was acquired to provide the baseline BOLD 
signal without any stimuli or event. The next two scans were an iBH fMRI 
paradigm, which was repeated twice for additional quality assessment and 
accuracy. During the iBH fMRI paradigm, the subjects were asked to take a 
deep breath and hold their breath for 20 seconds followed by 60 seconds of 
normal-breathing recovery time. The deep inspiration was based on the 
VXEMHFW¶V RZQ FDSDFLW\ to take the deepest gasp that they were able to 
maintain. Figure 11 shows the schematic presentation of the iBH protocol. 
The subjects underwent another two scans with the same BOLD sequence 
parameters for the TCR protocol.  
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The overall scanning time for both the iBH and TCR protocols was 30 minutes 
without the anatomical scan and 35 minutes with the anatomical scan. 
However, one hour scanning time was allowed because the BP 
measurements as well as the TCR and iBH task preparations took extra time. 
Following the acquisition of the images, the data were written to an optical 
disc (CD or DVD) to be securely transferred and stored on the internal server 
of the Radiological Sciences department for further analysis.  
All of the study participants were anonymized with regard to all identifiable 
details. 
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Figure 11 :Sequential representation (from left to right) of iBH protocol instruction slides 
Used in the scanner to direct the iBH paradigm 
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4.4 Data analysis 
4.4.1 Pre-processing 
The raw data were transferred from DICOM to NIFTI format images in 
preparation for the analysis; this was performed using a (dtoa) command 
line on the in-house software of the Radiological Sciences department. The 
data analysis was performed using an FMRI Expert Analysis Tool (FEAT FSL) 
(v6.00;http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSL). The functional images 
acquired were volume registered, time shifted, motion corrected, and brain 
extracted. The functional images were co-registered to a standard MNI brain 
(MNI152, non-linearly derived, McConnell, Brain Imaging, Montreal 
Neurological Institute, Montreal, Canada). The total acquired volumes were 
time-shifted to a common temporal origin. FEAT FSL performs this 
automatically when the temporal derivative function key is on. The motion 
correction was performed to calculate for any translational or rotational 
gross head motion using a 6-parameter rigid-body registration. This is 
performed through realigning the images by minimizing the sum of the 
square of the residual signals. Images with severe motion related artefacts 
were excluded from further analysis (Motion larger than a voxel is defined 
as a severe motion correlated artefact). This is estimated from the MCFLIRT 
motion correction output parameter, which defines the absolute and relative 
corrected motion in millimetres [151]. Non-brain matter was removed from 
all volumes using the FSL automated Brain Extraction Tool [152]. 
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4.4.2 Regional time series extraction 
The functional images were segmented according to the tissue specific 
differences of dCA identified in the literature; accordingly the whole cortical 
grey matter (GM), and the white matter (WM) time series were extracted 
[22]. There is a strong relation between the cortical watershed areas and 
severe haemodynamic impairment in the brain. Furthermore, the 
haemodynamic nature of the watershed areas may be important in the 
diagnosis of the origin of thromboembolic stroke [69].  Therefore, additional 
regional analysis was performed to show the magnitude of signal intensity 
of the watershed areas in relation to the non invasive BP stimulation 
methods (TCR and iBH). The time series for the three watershed areas were 
extracted separately (two cortical border zones and internal border zone). 
Figure 12 shows the ROI used to extract the watershed areas signal intensity 
maps. The reactivity maps of the total co-registered volumes (120 volumes) 
were averaged for each subject and each stimulus. Furthermore, the whole 
brain reactivity maps in relation to each watershed area were interpreted on 
a voxel-wise basis.  
The regional segmentation was performed manually using the interactive 
FSL view toolbox (v4.0.1 http://www.fmrib.ox.ac.uk/fsl/fslview).  
1. Tissue specific CA metrics 
For the GM time series extraction, the signal were selected from WM, 
cerebrovascular fluid (CSF), and subcortical regions as an ROI first and then 
masked out from the whole cortical GM manually. This sub-step in the 
analysis helped in acquiring regionally segmented functional images for 
future re-analysis, such as comparing regional modifications in dCA metrics. 
The region specific time series for the BOLD signal change was extracted 
using the FSL MEANTS command line [153]. The Harvard-Oxford anatomical 
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atlas available in the FSL view toolbox was used as the standard atlas for 
regional identification.  
 
2. Regional watershed and CA 
For the watershed areas segmentation, a cluster of voxels available in each 
watershed area was manually selected as an ROI, based on the predefined 
watershed areas and the Harvard-Oxford anatomical atlas available in FSL 
(Figure 12) (so marked as WS1, WS2, and WS3 for the anterior cortical, 
internal border zone and posterior cortical border zones respectively). The 
time series of the BOLD signal was extracted from each ROI separately using 
the FSL MEANTS command line. These three regions (WS1, WS2, and WS3) 
were used as explanatory variables for FEAT FSL stats. The statistical F test 
tool function was used to threshold the effects of each contrast against zero 
base. The three regions were entered into the F-test as a function of [1,0,0], 
[0,1,0] [0,0,1] for the WS1, WS2 and WS3 areas respectively. This kind of 
modeling allows the complete fit to be tested against zero without having to 
define the relative weights of the basis function.  
3. Average whole brain dCA map 
Because of the lack of standardized input and difficulties in formatting 
individual BP regressors (due to the variable timing), group averaging was 
not attempted. Therefore, only illustrative images for single subjects are 
provided without group registration. 
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Figure 12: Watershed areas segmentation 
The left image explains the three watershed areas 
(http://www.radiologyassistant.nl). The right image is the ROI selected 
using the FSL view tools box (v4.0.1 http://www.fmrib.ox.ac.uk/fsl/fslview) 
(23 year male. iBH protocol, BOLD image). The image shows an axial slice 
with the three watershed areas selected in red (WS1, WS2, WS3). The ROI 
was selected in three consecutive slices for each watershed area. A single 
watershed area was selected exclusively for each functional MR image. The 
three ROI are shown in a single axial slice image for explanatory purposes. 
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4.4.3 Non invasive interventions to induce BP fluctuations 
4.4.3.1 Thigh-cuff release challenge 
 
During the TCR protocol the time points at which the sudden deflation 
occurred were standardized across all of the scans and subjects. The time 
of deflation and the minimum signal intensity after the thigh-cuff release 
were visually detected (Figure 13). The baseline BP before the deflation was 
calculated by averaging over the three minutes of recorded base line BP 
data. This average was used to estimate the post TCR recovery of the BP. 
The relation between the first and second TCR tests for each subject was 
examined to determine intra-subject repeatability. This intra-subject 
comparison was also performed for the iBH test. A paired student T test was 
used to compare the intra-subject results. The statistical tests were 
performed using the Statistical Package for the Social Sciences (IBM SPSS 
v. 21). 
  
 
117 
 
4.4.3.2 Breath-hold challenge 
 
The depth and duration of breath-hold affect the magnitude and dynamics 
of the BOLD signal response [114, 154], and thus may impact the estimated 
CA. The associated hypo/hypercapnia with respiratory challenges need to be 
accounted for when estimating the dCA metrics, because the ETCO2 level is 
affecting the cerebral haemodynamics as well as BOLD signal amplitude. 
When modelling respiratory challenges, either the recorded ETCO2 values 
(Capnograph measures) or the duration of the breath-hold are accounted 
for as the main confound of interest to estimate the corresponding CA 
changes [18, 93]. Invasive ETCO2 estimation using mass spectrometry is 
the ideal method to obtain the actual ETCO2 changes during breath-hold. 
However, the invasive ETCO2 measuring technique was not applicable in 
this study as our methods involved only non invasive techniques to estimate 
CA metrics. ETCO2 changes induced by 20-second breath holds were 
simulated in similar studies in the literature and modelled as linear ramps 
increasing gradually with a final amplitude of 1 [94]. This is a suboptimal 
way of representing ETCO2 changes but it is an acceptable practical 
alternative to avoid invasive measures.  Figure 14 shows the illustrative 
curve used to simulate the expected ETCO2 changes during the iBH. The 
real-time recorded BP changes associated with the breath-hold challenge 
were used as the main regressor. However, the ETCO2 fluctuation is one of 
the most important physiological parameters associated with breath-hold 
challenge. Therefore it is necessary to include it in the modelling of the 
breath-hold challenge. Thus, in this study, three dependent variables are 
incorporated with the corresponding BOLD signal changes: the expected 
ETCO2 changes (Figure 14), the duration of the breath-hold, and the real-
time recorded BP fluctuations, to better fit to the BOLD response. 
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Furthermore, each of these confounds is incorporated into the corresponding 
BOLD changes separately to examine the effect of each entity. Figure 14 
shows the schematic explanation for the BH modelling.  
Gradual accumulation of CO2 causes a transient BOLD signal increase 
because of the vasodilatory effects. However, the associated hypercapnia 
and hypertension may act synergistically to change the BOLD signal 
amplitude.  
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Figure 13: Thigh-cuff release test (TCR) in the scanner 
A: Time series of mean arterial blood pressure (MAP) changes in response 
to TCR, acquired by the Caretaker device within the MR scanner (23 years 
male subject). 
B: Corresponding BOLD signal amplitude change (sequence parameters, TR 
2000ms, TE 35ms, Flip angle 77, FOV 240 ×240, Slice thickness 3.6mm). 
The pink bar represents the time of the sudden release of the thigh-cuffs 
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Figure 14: Breath-hold test (modeling different variables) 
iBH modelling parameters used as confounds to the BOLD signal response. 
A: representation model for the duration of BH, entered as a block design 
function to FSL FEAT full model setup. B: representation of the expected 
ETCO2 changes in response to 20-second breath-hold, used as confound of 
interest to model the BOLD iBH paradigm. Adapted from similar study by 
Bright et al [94]. C: Real time beat-to beat arterial blood pressure from the 
Caretaker plethysmograph (single subject, 23 years male). The real time 
acquired MAP was used as a confound of interest to model the BOLD signal 
amplitude response to iBH. D: BOLD signal amplitude in response to 20s BH 
for the same subject (sequence parameters, TR 2000ms, TE 35ms, Flip 
angle 77, FOV 240 ×240, Slice thickness 3.6mm) 
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x Derived haemodynamic metrics 
The transfer function gain, phase and coherence between changes in arterial 
pressure and CBFV could estimate the transient changes in CBFV during 
rapid BP changes [130]. The response impulse function is calculated as 
inverse Fourier transform of the transfer function between CBFV and BP. 
These metrics cannot be directly applied on BOLD fMRI data. 
The signal amplitude of the BOLD fMRI depends on several underlying 
cerebrovascular parameters, most importantly CBF and CBV. Calculating the 
response function between the BP and the corresponding BOLD signal is 
important when estimating the dCA metrics [15]. The rate of recovery of BP 
and the BOLD signal were calculated from concurrent time points. The three 
time points were: when the BP stimulus started, when the maximum effect 
occurred, and when recovery to the baseline was visually identified (Figure 
13 and 14). The respective three time points were determined on BOLD time 
series. 
 The sampling rate of the plethysmographic BP measurement devices 
depends on the heart rate, and thus a BP reading was recorded at the 
beginning of each cardiac cycle. In other words, the time interval between 
the recorded BP values varied according to the heart rate at the given time. 
This is a major restriction for intra-subject and inter-subject averaging.  
Usually a resampling at a common sampling rate for all sets of data would 
be the optimum solution for such variables. However, resampling negatively 
affects experiments that are strictly dependent on the quantitative change 
that happens in a relatively short period of time (20 seconds in our 
example). Therefore, the times at which the BP events occurred were 
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selected and accordingly the BP time point of maximum effect was visually 
identified and matched to the corresponding BOLD signal.  
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The rate of change after stimulus was calculated for each BP event and the 
corresponding BOLD signal changes across subjects. The rate of change Ʃ
for the BOLD signal was calculated by subtracting the percentage of the 
post-stimulus minimum BOLD signal from the recovered signal (=baseline 
BOLD) divided by the baseline BOLD signal amplitude to represent the step 
change.  
ܴ െ ݎ݁ܿሺܤܱܮܦሻ ൌ ߂ܤܱܮܦ݊ࢤࢀሺࡿࢋࢉ࢕࢔ࢊ࢙ሻ 
߂ܤܱܮܦ݊ ൌ ܵݎ݁ܿ݋ݒ െ ܵ݉݅݊ࡿ࢘ࢋࢉ࢕࢜  
߂ܶ݅݉݁ ൌ ܶݎ݁ܿ݋ݒ െ ܶ݉݅݊ 
 
Srecov= BOLD signal amplitude at baseline  
S min = minimum post-stimulus BOLD signal amplitude 
Trecov= time at which the BOLD signal recovered to baseline 
Tmin= time at which the BOLD signal reached the minimum post-stimulus 
amplitude 
 
The same equation was used to calculate the rate of change in MAP. 
ܴ െ ݎ݁ܿሺܯܣܲሻ ൌ ߂ܯܣܲ݊ሺ݉݉ܪ݃ሻ߂ܶ݅݉݁ሺݏ݁ܿ݋݊݀ݏሻ  
߂ܯܣܲ݊ ൌ ࡹ࡭ࡼݎ݁ܿ݋ݒ െ ࡹ࡭ࡼ  ሺ݉݉ܪ݃ሻܯܣܲݎ݁ܿ݋ݒ  
߂ܶ݅݉݁ ൌ ࢀݎ݁ܿ݋ݒ െ ࢀ  ሺ݅݊ݏ݁ܿ݋݊݀ݏሻ 
 
MAP recov= Mean arterial blood pressure at the baseline.  
MAP min= minimum post-stimulus mean arterial blood pressure  
Trecov= time at which the MAP returned to the baseline 
Tmin= time at which MAP reached the minimum post-stimulus value. 
 
124 
 
 
Usually, IRUODUJHUVDPSOHVWXGLHVQ, an autoregulatory index (ARI) is 
generated by fitting the ten possible CBF response template curves, scaling 
in between 0-9 (0 is absence of autoregulation and 9 is best observed 
autoregulation) [22]. Nevertheless, the autoregulation can also be 
represented by modelling the dynamic relationship between the CBF and BP 
[32]. The CBFV measures from the TCD have been considered as a valid 
surrogate marker of CBF [7]. Furthermore, Aaslid et al (1989) estimated CA 
metrics using CBFV and MAP measured by TCD and Servo-cuff system 
respectively [6]. They estimated the rate of regulation after thigh-cuff 
release in 10 healthy volunteers. The rate of regulation RoR after the fast 
blood pressure drop was calculated DV WKH Ʃ&95Ʃ7, which defines the 
rate at which cerebrovascular reactivity (CVR) changes. This rate depends 
RQƩ0$3 and full haemodynaPLFUHFRYHU\ZLOORFFXULIWKHƩ&95DQGƩ0$3
are equal. Hence the estimated RoR was defined as:    ൌ H?H?H?H?ȀH?H?H?H?H?H?×103[6] 
Considering the BOLD signal amplitude response as an indirect indicator of 
CBF change, a BOLD based CA metric could be estimated using a similar 
model using the transients of the BOLD signal amplitude and the MAP step 
changes induced by the TCR and iBH methods.  
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4.5 Results 
4.5.1 Thigh ±cuff release 
The results of the MAP responses to the TCR method are comparable to the 
previous results obtained outside the scanner (Figure 9 & 13). Figure 13 
shows the BP and corresponding BOLD signal amplitude change in response 
to the TCR protocol. The sudden release of the inflated thigh-cuffs induced 
simultaneous changes in the MAP and BOLD signal amplitude in five out of 
six subjects. The results of the first and second TCR were compared for each 
subject and there was no significant difference (P=0.72). The percentage 
change response across all accepted scans was (22-31 %) for MAP and 
(1.55-3.63 %) for the corresponding BOLD signal amplitude change. The 
rate of regulation (RoR) was (10.27±5; GM, 6.93±4.8; WM, 11±5.5; WS, 
mean±SD) (Table 9). The average time for recovery from the maximum 
stimulus effect to the baseline was (15±6 s; mean±SD) for the BOLD signal 
and (20±9 s; mean±SD) seconds for the MAP. Thus, the BOLD signal 
showed a 25% faster response compared to the MAP. Table 9 summarizes 
the calculated CA parameters for all of the subjects. 
For the regional analysis, the time interval from the maximum stimulus 
effect to recovery was (11±0.5 s; mean±SD), (14±1 s; mean±SD), (16±3 
s; mean±SD) for the WS1, WS2 and WS3 respectively. For the (22-31%) 
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change in the MAP the corresponding percentage BOLD change was (1.98-
1.99%), (2.11-3.63%), (2.1-2.55 %) for the WS1, WS2 and WS3 areas 
respectively.  
The group averaging for the reactivity maps is not illustrated because the 
averaging across the subjects resulted in an instant error of function, for the 
same reasons described in the methods. 
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Table 9: Estimated CA parameters for five accepted TCR measures 
CA parameters for grey matter GM, white matter WM, and averaged 
watershed areas WS. Individual TCR measures are averaged over two scans 
for each individual. The intra-individual means were calculated by averaging 
the numerical values rather than the curve response. Averaging across curve 
responses may attenuate the effects of the coupled BOLD signal and BP 
changes because of the time latency.  
5R55DWHRI UHJXODWLRQƩSDUDPHWHUV are for the regional Blood Oxygen 
Level Dependent %2/'VLJQDOFKDQJHVƩ%2/'DQGmean arterial blood 
pressure FKDQJHVƩ0$3 
  
Subjects Parameters GM-BOLD WM-BOLD WS-BOLD MAP mmHg 
TCR1 ȴƉĂƌĂŵƚĞƌƐ 0.04 0.02 0.04 0.29
RoR 12.26 6.90 12.41
Precentage changes 2.70 1.89 2.77 26
TCR2 ȴƉĂƌĂŵĞƚĞƌƐ 0.03 0.02 0.05 0.39
RoR 6.23 3.66 9.16
Precentage changes 2.49 2.30 2.33 31
TCR3 ȴƉĂƌĂŵĞƚĞƌƐ 0.05 0.05 0.05 0.7
RoR 13.72 14.29 15.43
Precentage changes 3.16 3.11 3.50 30
TCR4 ȴƉĂƌĂŵĞƚĞƌƐ 0.02 0.01 0.02 0.53
RoR 2.70 1.75 2.56
Precentage changes 1.87 1.55 1.98 27
TCR5 ȴƉĂƌĂŵĞƚĞƌƐ 0.04 0.02 0.04 0.31
RoR 16.45 8.06 16.13
Precentage changes 3.50 3.12 3.63 22
Averages ȴƉĂƌĂŵĞƚĞƌƐ ?ŵĞĂŶц^ ?(0.03±0.01) (0.02±0.01) (0.03±0.01) (0.45±0.17)
RoR (mean±SD) (10.27±5) (6.93±4.8) (11±5.5)
% changes (mean±SD) (2.72±0.6)% (2.39±0.7)% (2.84±0.7) (27±3)%
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4.5.2 Inspiratory breath-hold method iBH 
The results of the MAP responses to the iBH test confirm the results obtained 
for the iBH test outside the scanner. The inspiratory breath holds of 20 
seconds induced sufficient changes in the MAP and BOLD signal amplitude. 
The averaged percentage change from the baseline was a (19-23%) 
decrease for the MAP and a (1.95-3.14%) for the BOLD signal amplitude. 
The results of the repeated iBH tests for each subject were not significantly 
different (P= 0.3). The rate of change was (0.61±0.15) for the MAP and 
(0.03±0.01; GM, 0.02±0.01; WM, 0.04±0.01 WS, mean±SD) for the BOLD 
signal amplitude. The rate of regulation (RoR) was (5.06±1.5;GM, 
3.5±1.17;WM, 6±1.7; WS; mean±SD). Table 10 summarizes the estimated 
parameters for all of the subjects. The time interval from the maximum 
stimulus effect to the recovery point was (15.5±5s GM, 14±3 s WM, 17±2s 
WS; mean±SD) for the BOLD signal, and (24.7±11, mean±SD) seconds for 
the MAP. 
The reactivity analysis for the BP change and ETCO2 change simulation 
model resulted in a relatively similar distribution of signal intensity 
distribution in the brain. Meanwhile, the reactivity maps for the BH period 
model showed a slightly different distribution and larger signal amplitude. 
The combined effects of the BP and ETCO2 simulation resulted in a similar 
distribution as for the separate confounds.  Figure 15 shows three reactivity 
maps generated for the iBH test, using the three different models separately 
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(BH-period, ETCO2 simulation curve, and real time recorded BP data) and 
also for the combined effects.  
 
 
Table 10: summary of CA parameters calculated for iBH method 
Whole cortical grey matter (GM), white matter (WM), and averaged 
watershed areas for each individual and the average over four subject 
measures. The individual measures are averaged over two iBH stimuli 
each. RoR is the rate of regulation after the stimuli. Max effect ratio is the 
ratio of maximum step change after the stimulus, and CA is the estimation 
of cerebral autoregulation
Subjects Parameters GM-BOLD WM-BOLD WS-BOLD MAP mmHg 
BH1 ȴƉĂƌĂŵƚĞƌƐ 0.03 0.03 0.04 0.45
RoR 3.51 3.04 4.09
Precentage changes 2.06 2.18 3.11 22.00
BH2 ȴƉĂƌĂŵĞƚĞƌƐ 0.04 0.03 0.05 0.80
RoR 5.56 4.17 6.94
Precentage changes 2.64 2.70 2.88 23.50
BH3 ȴƉĂƌĂŵĞƚĞƌƐ 0.03 0.02 0.04 0.69
RoR 4.35 2.17 5.07
Precentage changes 3.12 2.50 3.14 21.30
BH4 ȴƉĂƌĂŵĞƚĞƌƐ 0.05 0.04 0.06 0.52
RoR 6.87 4.81 7.97
Precentage changes 2.19 1.94 2.30 19.20
Averages ȴƉĂƌĂŵĞƚĞƌƐ ?ŵĞĂŶц^ ? (0.03±0.01) (0.02±0.08) (0.04±0.01) (0.61±0.15)
RoR (mean±SD) (5.06±1.5) (3.5±1.17) (6±1.7)
% changes (mean±SD) (2.55±0.4)% (2.33±2.86)% (2.85±3.4)% (21.4±2)
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Figure 15 Reactivity analysis of brain, for iBH challenge (23 years, male subject)  
This is a contrast map denoting the magnitude of the signal intensity change. 
Reactivity map of a healthy volunteer showing signal intensity change 
relative to three different confounds A:  BH period used as the regressor of 
interest B: Simulated ETCO2 curve used as the regressor of interest C: Real-
time recorded beat-to-beat MAP used as the confound of interest D: 
Combination reactivity map (BP, and ET simulation curve).  
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4.5.3 Statistical analysis  
The autoregulation parameters obtained from the BH and TCR in grey matter, white matter 
and the watershed areas are expressed as mean±SD (Table 9 &10). The differences in the 
rate of regulation in the BOLD signal for the BH and the TCR methods were compared and 
analysed using the Student t test. In all of the tests, P ӊ 0.05 was considered statistically 
significant. The regional RoRs for the WM, GM and WS areas were calculated separately 
and then the mean RoR of three regions was calculated (Table 9 &10).  
The reproducibility of the calculated RoR obtained by the breath-hold and thigh-cuff release 
challenge was analysed according to the method of Bland and Altman [155].With the 
difference between the RoR for the BH and TCR challenges, the standard deviation of the 
difference (SDD) was calculated (Figure 16). The SDD is a measure of the repeatability of 
the method. The 95% limits of agreement were calculated (i.e., the mean difference±1.96 
 SDD). The scattered distribution of the results above and below the mean difference 
denotes the minimum bias of one approach versus the other. The results of the statistical 
tests show good agreement between the RoR results obtained with the TCR and iBH 
methods.   
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Figure 16 Bland-Altman plots  
RoR s compared between the BH and TCR challenges. The top panel includes the region specific 
RoRs (Grey matter GM, white matter WM, and Watershed areas WS). The bottom panel shows the 
Bland-Altman plot comparing between the mean BH and TCR challenge for the averaged RoRs for 
four healthy volunteers. 
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4.6 Discussion 
The sudden release of thigh cuff and the inspiratory breath-hold challenge 
both induced simultaneous MAP and BOLD signal amplitude changes. The 
time interval for the BOLD signal amplitude recovery after the event was 
faster than the MAP recovery for both methods suggesting intact cerebral 
autoregulation. The MAP change was higher and more prompt in response 
to the TCR than the iBH method; the difference was not statistically 
significant (P= 0.72). The resultant percentage BOLD signal change was 
relatively close for the iBH and TCR (2.5±1%, mean±SD). The BOLD signal 
response in the whole of the cortical GM and WM tissue was comparable to 
previous studies (GM 1.81±0.67%, WM 1.18±0.59%, Horsfield et al 2013) 
and consistent across the TCR and iBH methods (0.5-2.2 %, Emir et al 2008) 
[22] [15].  
Beat-to-beat BP changes associated with TCR have been reported for studies 
outside the scanner [17].  Furthermore, regional variation in the BOLD 
response to TCR has previously been detected in a 1.5 T MR scanner [22].  
Nevertheless, in this study, the beat-to-beat arterial BP measures acquired 
within the scanner (at 3T) were used in combination with the BOLD signal 
amplitude to estimate dCA metrics. This is the first study that could record 
the real time ABP at 3T scanner for the best of the DXWKRU¶V knowledge. 
Controlling for the beat-to-beat ABP could improve the derived dCA metrics 
using TCR method. Acquiring concurrent BOLD and ABP changes allows 
deriving the rate of regulation after the BP disturbance following the sudden 
release of the thigh cuff. This improves the physiological interpretation of 
the autoregulation index and may be clinically significant for estimating dCA 
metrics in haemodynamically unstable patients.  
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The recorded BP-response to the iBH method in this study and also outside 
the scanner, in the previous chapter, showed a sufficient BP change to allow 
dCA activation. This was further confirmed by corresponding BOLD signal 
changes. A short breath hold of 20 seconds causes transient hypercapnia 
and a BOLD signal deflection in opposite direction to the expected 
hypercapnia effect. The respiratory challenge is associated with the gradual 
accumulation of CO2 in brain. CO2 is a potent vasodilator that increases the 
CBF in the brain [15].  The relationship between ETCO2 and blood flow is a 
linear relationship with CBF almost doubling as PaCO2 increases from 40-
100 mmHg. Buxton et al (2010) demonstrated a linear association between 
CBF increase and the corresponding BOLD signal change, as represented in 
Figure 17 [156]. In our experiments, the BOLD signal response to a 20-
second iBH resulted in a gradual increase in signal, which is in line with the 
accumulated CO2 effect. This was followed by a larger decrease in signal 
intensity, which may be caused by the BP drop (Figure 14).  
Recent studies have shown that even subtle variations in the rhythm of 
respiration that occurs at rest can induce a BOLD signal change [110]. The 
amplitude of BOLD signal change in response to different breath-hold periods 
(9 s, 11 s, and 20 s) has been examined previously [94]. Two confound 
variables have been used to model the breath-hold response effect; the 
breath-hold period and the measured ETCO2 change. However, another 
physiological alteration associated with breath holding is systemic arterial 
blood pressure changes. To the best of the DXWKRU¶Vknowledge, no studies 
that have examined CA in response to respiratory challenge have accounted 
for the associated BP changes (Figure 13 and 14). The BP drop in response 
to the Valsalva manoeuvre has been used to estimate dCA metrics [150]. In 
this study, the iBH resulted in a relatively similar response curve to the 
Valsalva manoeuvre (Figure 14). The transient BP increase at the beginning 
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of the iBH might be caused by the transient sympathetic activation 
associated with the voluntary act of breath holding, which tends to increase 
the BOLD signal amplitude.  
The CBF decreases in response to induced fast BP drops; this could lead to 
transient neuronal hypoxia, which activates the regulatory modulators. The 
regulatory modulators decrease the vascular smooth muscle tone to allow 
vasodilatation [157]. There is a time delay from the onset of excreting 
regulatory modulators until the effects are fully developed on vascular 
smooth muscle tone, which may lead to an overshoot in CBF response [6].  
Dynamic CA metrics estimated from MAP and CBFV recordings from TCD and 
TCR have been shown to detect pathological changes in CA, but the wider 
clinical application is hindered by the limited spatial resolution of TCD [17]. 
Detecting the regional variations in CA may be important in the follow-up 
and prognosis of neurodegenerative diseases, as well as tumor and stroke 
[69]. In this study, GM tissue showed faster recovery than WM after a BP 
event; this is physiologically predictable because of the higher metabolic rate 
of GM compared to WM [158]. The rates of regulation for the GM and WS 
areas were relatively similar (Tables 9 & 10).  The multiple source vascular 
supply of the watershed area classifies the region as less haemodynamically 
active in response to fast BP changes, and thus less reactivity response is 
expected. However, the GM and WS areas showed close RoR in this study. 
This is probably because this experiment studied only healthy volunteers 
with intact dCA. Furthermore, the specificity and sensitivity of the software 
used to segment and extract the regional BOLD signal amplitude may have 
affected the results.  
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Figure 17 Graphical representation of the relationship between CBF and PaCO2 [131]. 
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4.7 Limitations 
There were two main types of limitations in this study: CA related and 
technical related limitations. The CA related limitations were similar to the 
published studies on CA that are discussed in Chapter two. These are mainly 
related to the non-stationary nature of CA, multi variable reliance (CBF, CBV, 
and CMRO2), as well as the temporal and spatial resolution of the applied 
techniques.  
This study included only healthy adult volunteers. Developing a diagnostic 
technique for such a dynamic process should include comparisons with 
patient group implementations. Another source of bias in this study is the 
small sample size; this was due to the restricted timescale of the study. In 
order to take the results of this study forward, the sample size should be 
increased and patient groups such as hypertensive cases should be added. 
Increasing the number of participants may also improve the method of intra- 
and inter-comparisons due to the non-stationary nature of CA.  
Technical restrictions included sequence related and non-sequence related 
limitations. Despite the high spatial and temporal resolution of BOLD MRI, it 
is highly dependent on several other factors that are directly related to the 
cerebral haemodynamic parameters, such as hematocrit, CBF, CBV and 
CMRO2 [68] . Furthermore, the BOLD signal, similar to any fMRI data, has 
two main kinds of noise: thermal noise and physiological noise. The new 
high-field MRI systems could improve the apparatus sensitivity and stability, 
which are responsible for the thermal noise [159]. Noises of a physiological 
origin can be diminished by selecting a low flip angle in BOLD MRI [160]. In 
our experiments, the flip angle was selected according to the Ernst equation 
[161].  
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The motion artefact associated with the TCR and iBH methods was another 
scanning related limitation. Despite maintaining a 40° knee flexion angle 
during the scanning and adding motion correction into the analysis, there 
were some instant motion artefacts that led to the rejection of some scans.  
Other technical issues were related to the BP measurement method. The 
Caretaker system was very sensitive to external noises. The long connecting 
tube that connects the outer port to the finger-cuff in the scanner affected 
the coupling pressure and led to some repeated drop-outs during the data 
acquisition.   
Furthermore, the cold temperature that helps to maintain the working 
environment for the magnet affected the volunteers¶ body temperature. 
Maintaining a warm periphery is important to allow enough vascular-bed 
circulation while acquiring BP measures using the Caretaker and other finger 
plethysmographic devices. Portable self-heating hand pads were provided to 
the volunteers before, but not during scanning. The MRI safety team in the 
Department of Radiological Sciences examined these pads beforehand; the 
pads were not qualified as MR compatible. These pads contain a mixture of 
iron dust, activated charcoal and cellulose, and are capable of maintaining 
instant heat production (122-130 F) for up to 8 hours.  
The Caretaker device was not triggered to the signal from the MR scanner 
during the BP acquisition process. This led to a gap of a few seconds between 
the BP and MR signal data. The Caretaker could accept or deliver a trigger 
signal by pairing it with another device (MP 150, Biopac ®); this was not 
available during this study.  
Another way of identifying the actual time R-R intervals is by registering the 
beat-to-beat BP measures to the recorded physiological data from the 
attached cardiac vector. The physiological recordings were collected and 
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saved on Spike software (Cambridge Electronic Design, CED). However, to 
compare the R-R intervals and the BP data, it was necessary to transfer the 
analog data from Spike to digital format. Unfortunately this was not possible 
during the time of this study because the corresponding person from CED 
was on leave at the time. 
Another limitation was the lack of ETCO2. The breath-hold method was 
performed without ETCO2 recordings because an MRI compatible 
Capnograph was not available in the department. An MRI compatible 
Spirometer is an alternative method.  However, the sampling rate for the 
Datex spirometer (Datex Ohmeda anesthesia machine, GE healthcare) to 
record the ETCO2 value is every five minutes and this was not compatible 
with our experiment. The lack of ETCO2 measures may be a major restriction 
for studies that include the rate and depth of continuous breathing. Our 
study included a 20-second breath-hold during which the Capnograph could 
not estimate the ETCO2 measures. An alternative method that can be 
applied to deal with this issue is explained in detail in the data analysis 
section. Temporal resolution could be another limitation of this study, 
providing higher temporal resolution sequence may allow disentangle BP-
induced transient change from more prolonged hypercapnia effects, 
particularly if the associated ETCO2 metrics could be acquired on continuous 
basis. We are aware of dCA studies that have incorporated ETCO2 measures 
into CBF measures to calculate the transfer function between both variables 
using the principal dynamic modeling technique [126]. This will be 
considered in our future studies. 
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Conclusion  
In conclusion, we have shown that the iBH and TCR methods can both induce 
a BOLD signal change in response to the induced MAP changes at 3T MRI 
scanner.  The measured beat-to-beat BP data was in line with the 
corresponding BOLD signal changes. The signal amplitude recovered back to 
the baseline after the BP-event faster than the MAP.  Connecting the 
Caretaker device to the MR scanner signal can improve the temporal 
registering between the MAP and the corresponding BOLD signal. Using a 
concurrent BOLD signal and BP data to calculate the rate of regulation after 
BP stimulus could better evaluate the reliability of estimating dCA metrics 
using physiological fMRI. The TCR method could be more reliable to be 
applied to induce dynamic changes in less competent subjects and 
unconscious patients. The iBH method is more subjective and requires more 
cooperation therefore it might be not reliable for critically ill patients. 
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Chapter 5 
5 Time Resolved Phase Contrast Angiography (4D PC MRI) and 
Breath-Hold method 
5.1 Background 
The iBH method used to induce dynamic changes in the previous chapter 
resulted in a (11-20%) change in MAP and a (0.5-1.8%) corresponding 
BOLD signal change. With that in mind, it is important to note that the BOLD 
signal change is sensitive to several underlying parameters, and even subtle 
variations in the depth and rhythm of respiration at rest can induce a BOLD 
signal change [109, 110]. Furthermore, the BOLD signal amplitude response 
depends on several parameters in addition to the CBF, such as the baseline 
CBV, the haematocrit and the metabolic rate [83].  
In the previous chapter, an inspiratory breath holding challenge was used to 
induce transient hypercapnic responses followed by a transient BP drop and 
the rate of response of the delayed percentage BOLD signal amplitude 
reduction was used to estimate dCA metrics. However, quantifying the 
absolute CBF and CBV change to a breath-hold test would give a better 
insight into the physiological aspects of this method. Hereafter, we have 
used the multidirectional high temporal capability of 4D PC MRI to 
preliminarily measure the vessel specific haemodynamic response to a 
respiratory challenge test, in two healthy volunteers. The aim of the study 
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was to show the feasibility of 3D magnetic angiography in detecting and 
quantifying the transient haemodynamic responses. Two types of breath-
hold method, iBH and BH, were used to induce dynamic change response 
quantification by 4D PC MRI to allow a quantitative comparison between the 
two methods. As stated in Chapter three, they resulted in different MAP 
response curves outside the scanner. 
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5.2 Methods and Materials 
Two healthy volunteers (23 and 24 years old; males) were recruited for this 
feasibility study. The details of the ethics approval, subject preparation and 
BP acquisition are explained in the methods section in the previous chapter.  
5.3 Data acquisition 
The scanning was performed in a 3T GE 750 Discovery scanner. A time of 
flight (TOF) image was acquired before the phase contrast to show the 
anatomy of the cerebral vessels and localise the slice position. Following 
that, a 4D PC MRI sequence acquired for the Circle of Willis at the base of 
the skull to measure the flow and velocity through three major arteries: the 
BA, and the left and right ICA. The sequence parameters for 4D PC MRI were 
(RT 4.627, ET 1.908, Spatial Res 1.562, Flip Angle 15, Scan time ~ 4 
minutes, Voxel size: 1.17 X 1.17 X 8mm, Image matrix: 256 X 256, FOV 
300 X 300 X 96 mm, 12 Slices over 20 TF X 38 ms = 722 ms, velocity 
encoding 80 cm/second).  The 4D PC MRI sequence is provided by a license 
DJUHHPHQW ZLWK ³'U 0DUFXV $OOH\ /XFDV 0HGLFDO &HQWUH 5DGLRORJLFDO
Sciences Labs, University of Stanford, &$86$´ The sequence parameters 
for the TOF were (RT 23, TE 3 ms, space between slices 0.5, display FOV 
156, flip angle 15).  
The 4D PC sequence was repeated three times for each subject. The first 
scan was a baseline scan.  The second scan was an iBH test with 20-second 
iBH intervals at the beginning of each minute throughout the four minutes 
of scanning (33% breath-holding and 67% normal breathing). The third scan 
was a non-inspiratory breath hold (BH) with similar settings to the iBH.  
 
 
144 
5.4 Data Analysis 
The acquired data were saved on an internal server to be reconstructed and 
transferred later to DICOM format. The data reconstruct was performed on 
a 64-bit Linux system PC. Two programs, (MEDICOR) and (OFFLINE.RECON) 
were used to develop the DICOM format files with mag, speed and three 
directions of flow. The dataset was corrected for eddy current induced phase 
offsets. Gyro tools software (GT-flow, Gyro Tools LLC, Winterthur, 
Switzerland) (www.gyrotools.com) was used to visualize and interpret the 
multidirectional phase contrast MRI flow datasets. The net flow and through-
plane velocities for the BA, and right and left ICA arteries were plotted, after 
which the vessel diameters were selected semi-automatically (Figure 18). 
The vessel diameter selection has automatic and manual options on the GT-
flow software. After selecting the diameter of the vessel on the magnitude 
image the selection is automatically registered to the phase image from 
which the flow velocity information is plotted.  
The flow and velocity data output from the GT-flow is divided over 20 phases 
for a single cardiac cycle (Figure 18) and (Table 11). Phase contrast MRI 
acquires flow and velocity data using a time-averaged signal over several 
cardiac cycles. Hence, the velocity and flow information curves are displayed 
as a single cardiac cycle containing information about the average flow and 
velocity for the total cardiac cycles throughout the acquisition time. Table 
11 shows the flow velocity and volume measures from the GT-flow for one 
subject.  
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Figure 18: 4D PC MRI data analysis from GT-flow 
(23 years old, male, four minute acquisition time) 
A: selected arteries (BA, left and right ICA). The right side is a magnitude 
image (classic blood bright image), mostly for anatomical orientation. The 
left side is a phase (velocity) image in which the grey value represents the 
velocity in that voxel (grey denotes flow velocity towards the viewer and 
white is the flow direction away from the viewer) 
B: Average flow velocity through BA. Averaged into one cardiac cycle and 
sub-divided into 20 phases. The green line (upper-line) represents multi-
direction flow velocity and the black line (lower-line) is the through-plane 
flow velocity. 
  
A 
B 
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Table 11 Example of flow velocity output data from GT-flow software 
(Basilar artery at baseline) (23 years; male) 
Data averaged for total cardiac cycles. The time series is subdivided into 20 
phases of single cardiac cycle. Area represents the diameter of the artery. 
Net is the total volume in millilitres/second. Flow is the blood flow at the 
selected slice. Avg, is the average of velocity in all directions, TPVel is the 
through plane velocity. Note that the Flow is given in cm/s from the GT flow.  
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5.5 Results 
The vessel specific flow and velocity information were averaged for two 
scans and three vessels at the baseline, iBH and BH (Table 12) (Figure 19). 
The average flow (averaged at intra-subject level, for 4 min acquisition time 
total cardiac cycles, 2 subjects) at the baseline was lower for BH than iBH 
conditions (Figure 19). There was no significant change in the flow curve 
between the different vessels (Figure 20). Furthermore, the cerebral blood 
flow curve was slightly higher for iBH compared to BH. The 33% breath hold 
resulted in a corresponding 29% CBF change for the iBH protocol and a 7.5% 
average change for the BH (Table 12). 
The end diastolic velocity (EDV) and peak systolic velocity (PSV) values were 
acquired at the same slice for each vessel (BA, right and left ICA). Figure 21 
summarizes the vessel specific PSV and EDV values acquired at the baseline, 
iBH and BH. The PSV and EDV values were averaged for both subjects. As 
shown in Figure 21, the average PSV and EDV are vessel-diameter 
dependent. The ratio between PSV and EDV for each method (baseline, iBH 
and BH) was calculated to estimate the variable flow responses of each 
method. 
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Figure 19: Average flow velocity 
(Averaged for two subjects and three main intracranial arteries BA, Rt and 
Lt ICA), at baseline (blue line), during inspiratory breath-hold (iBH- red line) 
and non-inspiratory breath hold (BH-green line). 
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Figure 20 Flow curve through three different arteries 
During, A: inspiratory breath-hold (iBH), B: non-inspiratory breath-hold 
(BH), and D at the baseline. BA basilar artery, LT-ICA left internal carotid 
artery, RT-ICA right internal carotid artery. 
A B C 
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Figure 21: Peak systolic and end diastolic velocities 
A, peak systolic velocity (PSV) and end diastolic velocities (EDV) averaged 
for two subjects at baseline, iBH and BH. (for three major arteries BA, right 
and left ICA)  
B, PSV/EDV ratio for the three arteries at baseline, iBH and BH respectively. 
 
BA Basilar artery, LT-ICA left internal carotid artery, Rt-ICA right internal 
carotid artery, iBH= inspiratory breath-hold, BH= non-inspiratory breath-
hold.   
 
 
 
  
A 
B 
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Table 12 Flow velocity for two subjects at averaged 20 phases of cardiac 
cycle time points. At baseline, at 33% inspiratory breath-hold (iBH), and at 
33% non-inspiratory breath-hold (BH) 
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5.6 Discussion 
The results show an increased flow in response to iBH 29% and BH 7.5%. 
The difference between the iBH and BH was statistically significant for the 
averaged twenty phases of the cardiac cycle (P=0.012). There were no 
recorded changes in the vessel diameter at the baseline, iBH and BH. There 
was no significant difference for the flow response between the three vessels 
(P=0.75).  
Preliminary results in two subjects show in principle the feasibility of contrast 
free non invasive time resolved 4D phase contrast MR angiography to 
quantify the absolute volume flow within specific cerebral vasculature. The 
beat-to-beat arterial blood pressure was measured continuously within the 
scanner during the MR angiography acquisition (Figure 22). However, the 
major limitation of the study was the averaged signal over several cardiac 
cycles, which led to missing the time-specific flow information within 
sequential cardiac cycles. Averaging for the total cardiac cycles is essential 
in 4D MRA technique to provide sufficient SNR and time resolved 3D 
coverage.   Another limitation was the small number of volunteers scanned 
for this study; this limits the statistical value of comparing the CBF change 
responses.  Only two healthy volunteers were scanned for this feasibility 
study because of the restricted time of the study. The sequence was lost 
after a software upgrade of the 3T GE scanner because of the incompatibly 
with the new software version. Furthermore, this feasibility study was 
performed to show the possibility of measuring volumetric response changes 
in the cerebral haemodynamics under the effect of non invasive physiological 
intervention. 
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The observed increased flow in both subjects in response to iBH and BH 
shows the feasibility of this technique for identifying induced changes in the 
cerebral haemodynamics.  
Cardiac gating is a technique that allows for collecting the same data at the 
same time points in the cardiac cycle for each repetition of the pulse 
sequence [162]. It has the advantage of monitoring the cardiac cycle 
prospectively to initiate RF application as well as retrospectively determining 
the R-R interval within the acquired data. The only drawback is that it has 
negative effects on time dependent protocols.  The averaged signal for total 
cardiac cycles leads to omission of specific haemodynamic information in 
particular cardiac cycles. This led to missing the linear relation between the 
coupled flow response and the acquired beat-beat BP in this experiment. 
Furthermore, the time point at which the BH was performed was missed 
after averaging. The breath-hold time points were at the beginning of each 
minute during the four minutes of the scanning time. 
The iBH induced a (1.5-3.2 %) change in the BOLD signal amplitude. As 
discussed previously, several parameters contribute to developing the BOLD 
signal amplitude. Furthermore, the baseline cerebral blood volume is an 
important indicator of the estimated percentage BOLD signal change. This 
might also be imperative in phase contrast imaging.  The convoluted change 
responses during apnoeic phases and normal breathing in 4D PC MRI might 
de-emphasize the corresponding changes in flow velocity. Resampling and 
extracting the flow velocity separately for the apnoeic phase and normal 
pace breathing might provide a better understanding of the effects of 
baseline blood volume.  
The quantitative reproducibility of 4D PC MRI has been validated in previous 
studies [74]. The CBF response to transient breath-hold has been quantified 
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successfully using 2D PC MRI and 30-second BH, and ~64% increase 
observed in the volume flow of the cerebral vessels on breath holding [105]. 
This concurs with other study findings that have used acetazolamide to 
induce flow volume changes (40%-50%) [55, 163, 164]. The data sampling 
for 2D PC MRI depends on quantifying the haemodynamic difference 
between two predefined slices in a vessel i.e. the flow velocity is measured 
at two selected slices within the artery and the haemodynamic change is 
estimated in relation to the transit time between these slices [98]. 
The effect of the breath-hold periods was averaged over four breath-holds 
(20 seconds each) plus the total volume flow during recovery in-between 
the breath-holds (40 seconds each). In other words, the averaged flow 
velocity was acquired during 67% normal pace breathing and 33% breath-
hold (inspiratory or non-inspiratory). As a consequence, estimating the 
percentage of the absolute volume flow increase in response to the 20s 
breath-hold was not applicable at the time. However the 33% breath-hold 
resulted in a 7.5-29% increase in the total CBF (Figure 19&20). These 
findings could represent the CA response to transient hyperaemic changes. 
However, the exact time points of the CBF response change were not 
acquired because of the averaged signal for the total cardiac cycles.  
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Figure 22 Mean arterial blood pressure (MAP) during BH and iBH protocols 
Measured during, A non-inspiratory breath-hold (BH) and B inspiratory 
breath-hold test (iBH) (23 year old subject; male). Averaging across 
subjects was not possible because of heart rate variability and different 
breath-hold response timing.  
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5.7 Conclusion 
The results of this study show that it is possible to measure vessel specific 
volume flow through cerebral vasculature using time resolved 4D PC MRI at 
3T. The volume flow response at the baseline was slightly lower than the iBH 
and BH response changes. Furthermore, there was a slight difference 
between the total volume flow of the iBH and BH.  
The major limitation of this study was the small sample size as well as the 
eluded time points at which the volume flow response occurred. Matching 
the time points of the BH with the consecutive BP data was another limitation 
of the study.  Increasing the sample size and including patient groups will 
be necessary in future studies to evaluate the effects of a breath-hold test 
on absolute CBF changes. Using 2D PC MRI with two predefined slice 
locations may help to match the time interval of the acquired volumetric 
data.   
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6 Summary of the work presented in this thesis  
This thesis describes the feasibility of using functional MRI to assess dynamic 
cerebral autoregulation in healthy subjects. Furthermore, this thesis evaluates the 
common diagnostic methods used to estimate dynamic cerebral autoregulation 
metrics. In particular, it investigates non invasive approaches to fluctuate arterial 
blood pressure to allow stimulation of dCA metrics.  
The first chapter described the pathophysiology of cerebral haemodynamics and 
intact autoregulation. It outlined some of the cerebrovascular disorders that are 
either an outcome or a causal factor of impaired autoregulation. There are two 
types of autoregulation: static CA, which is cerebrovascular flow adaptation to 
chronic changes in ABP or CPP; and dynamic CA, which is CBF alternations in 
response to rapid arterial blood pressure fluctuations. The recent literature has 
pointed towards a potential benefit of dCA assessment in the diagnosis and follow-
up of several critical cerebrovascular disorders such as stroke, traumatic brain 
injury and dementia. CBFV measures from TCD are used to evaluate dCA metrics 
in health and disease. The limited spatial resolution of TCD is the only drawback of 
this technique.  The development of fMRI techniques has allowed the assessment 
of different CBF indices with high temporal resolution as well as anatomical 
orientation.  This has led to the observation of some regional heterogeneity of 
cerebral autoregulation.  
Chapter two systematically reviewed the consistency and reproducibility of non 
invasive physiological methods used to assess dynamic CA.  Measuring dCA metrics 
depends on several parameters: the CBF quantification tool, the ABP fluctuating 
method, the analysis methods, and the indices used to represent the autoregulation 
curve.  
The systematic evaluation of 34 studies that used fMRI or TCD to quantify dCA 
metrics in response to non invasive physiological ABP interventions has revealed 
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that there is no consistency or standardisation between CA evaluation studies. In 
the absence of a gold standard it is also not possible to define which method is 
best. The desired CA evaluation method should be accessible, non invasive and 
direct to allow its application in daily clinical practice.  The quality of CA metrics is 
related to the CBF quantification technique, the BP fluctuating method and the 
autoregulation modelling used. The major limitations could be related to the fact 
that CA is not a concrete value but rather a physiological phenomenon. This makes 
inter- and intra-individual comparisons of the metrics difficult. Different methods 
used to induce BP fluctuation and the effects of these methods need to be compared 
quantitatively and qualitatively.  
The third chapter described a pilot study that evaluated and compared the effects 
of several non invasive physiological interventions to stimulate ABP.  Measuring 
beat-to-beat arterial blood pressure is important in estimating dCA metrics in order 
to allow better physiological interpretation. To the best of WKHDXWKRU¶VNQRZOHGJH, 
no CA study has measured beat-to-beat ABP in a 3T MR scanner. In this pilot study, 
the MRI compatible Caretaker plethysmographic system was used to estimate 
continuous ABP from finger pulse pressure. Comparing the BP results with the 
validated Finometer plethysmographic device validated the results of the Caretaker. 
Different non invasive interventions were used to stimulate BP. These included 
thigh-cuff release, inspiratory breath-hold, non-inspiratory breath-hold, and cued 
deep breathing. The inspiratory breath-hold test resulted in a biphasic BP response 
change similar to the Valsalva effect. The different BP responses to iBH and BH 
were preliminary observations of this pilot study. Biphasic BP fluctuation may 
improve the dynamic CA activation. The TCR method resulted in sharp BP drops of 
sufficient amplitude. Thus the TCR and iBH methods were selected for use in the 
MR scanner to induce dynamic flow regulation in the brain.  
Chapter four in this thesis investigates the feasibility of estimating dCA metrics 
using Blood Oxygen Level Dependent BOLD signal fMRI. The beat-to-beat ABP 
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changes in response to the TCR and iBH tests were obtained at 3T MR scanner. The 
BOLD signal amplitude depends on the diamagnetic and paramagnetic properties 
of the oxyhaemoglobin and deoxyhaemoglobin levels in the blood. The signal 
intensity is mainly affected by the CBF but it is understood that it is also affected 
by other parameters such as CBV and the metabolic rate. The Time series of BOLD 
signal amplitude was extracted for different brain regions: GM, WM and the 
watershed areas (WS). The rate of regulation (RoR) of the BOLD signal amplitude 
was estimated as an autoregulation index. This is the rate at which the BOLD signal 
changes according to the underlying BP changes at the given time. The mean 
arterial blood pressure (MAP) changes in response to the TCR and iBH methods 
were comparable. The fMRI data indicated the BOLD signal amplitude change in 
response to the induced fast MAP changes. The GM and WS areas showed similar 
rates of regulation, and this was nominally higher than the WM RoR in both the TCR 
and iBH methods.  
Chapter five described a preliminary observational study that evaluated the effects 
of the iBH/BH method on CBF and CBFV. Time resolved 3D Phase Contrast 
angiography (4D PC MRI) was used to quantify the CBF and CBFV response to iBH 
in two healthy subjects. The 4D PC MRI data suggested a 29% CBF-increase in 
response to 33% iBH in a four-minute acquisition time.  
The main limitations of this study were the lack of ETCO2 measures and the small 
number of healthy volunteers recruited because of the restricted time of the study. 
Other limitations included the technical issues related to the Caretaker device and 
the beat-to-beat BP resampling, which may have led to blunting the BP-fluctuating 
curve.  
This study demonstrated the feasibility of mapping dCA metrics using functional 
MRI. Different non invasive physiological methods used to induce BP fluctuations. 
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Future studies including ETCO2 measures and patient groups may improve the 
physiological interpretation of dCA metrics. 
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Appendix 3  
Summary of the Caretaker output files  
Several files are saved automatically under the selected directory DIWHUDFWLYDWLQJ³VDYH
UHVXOWV´RSWLRQRQWKH*8,FRQWUROV\VWHP7KHVHLQFOXGH 
(ETC (asc) __ (time_date).dat contains raw data  
 ETC (press) __ (time_date).dat contains pressure information data  
ETC (log) __ (time_date).dat contains time information and comments written during 
acquisition process  
ETC(Results) __ (time_date).datcontain BP and all necessary information  
The files (log) and (Results) are containing the necessary information for recorded 
physiological data.  
The log file contains the time marks and notes that have been set by the operator. 
The Results file contains all the necessary BP component information including; the results 
of the analysis of the data stream, interbeat interval, systole, diastole, time positions (time 
VWDPSHGEDVHGRQWKHFRPSXWHU¶VFORFNZLWKPLOOLVHFRQGUHVROXWLRQDVZHOODVSDUDPHWHUV
that the algorithm calculates.  
 
 
184 
Appendix 4 
 
 
